Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,44884,0.043260709350194,0.034299946093367,-0.0239671849928053,0.110488603693193,0.207233810067133
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,41745,0.110201246313578,0.0395488704476666,0.0326854602361511,0.187717032391004,0.00533437489348315
LYZL2,Lysozyme-like protein 2,Physical activities,X1070.Time spent watching television (TV),45893,0.0295298269054467,0.0341084022529421,-0.0373226415103198,0.0963822953212131,0.386629019988446
LYZL2,Lysozyme-like protein 2,Physical activities,X1080.Time spent using computer,41726,0.00660449103335168,0.0369442909010977,-0.0658063191327999,0.0790153011995033,0.858121176486035
LYZL2,Lysozyme-like protein 2,Physical activities,X1090.Time spent driving,40786,0.00935875233771464,0.0385836727660452,-0.0662652462837339,0.0849827509591631,0.808351285167456
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1160.Sleep duration,47394,-0.00276213107800564,0.0323448513141465,-0.0661580396537328,0.0606337774977215,0.931947049948906
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32386,-0.00507740684182049,0.0128861040507426,-0.030334170781276,0.020179357097635,0.693574745214142
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32386,0.0115636042665584,0.0126759283528559,-0.0132812153050392,0.036408423838156,0.361663393597983
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32386,-0.00611231811952743,0.0147570992500679,-0.0350362326496606,0.0228115964106057,0.678741653437902
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32386,0.0178383527661786,0.0151837559380686,-0.0119218088724359,0.0475985144047931,0.240094997440766
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32386,0.00953156553428487,0.0155340388988973,-0.0209151507075538,0.0399782817761235,0.539501189913329
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32386,0.0323543416144082,0.0298262964344615,-0.0261051993971364,0.0908138826259527,0.278059108402994
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32386,0.00665974909244463,0.0304909177335322,-0.0531024496652784,0.0664219478501677,0.827109082976259
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32386,-0.00825812694158594,0.0217816958140066,-0.0509502507370388,0.0344339968538669,0.704599659275495
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32386,0.00800063543910583,0.016408488310761,-0.0241600016499857,0.0401612725281974,0.625851926538552
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32386,0.00322651870715653,0.0114391591227009,-0.0191942331733372,0.0256472705876503,0.777905054639396
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32386,0.021184104148671,0.0160510209271032,-0.0102758968684512,0.0526441051657932,0.186937928970699
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32386,0.00150618016262689,0.0092868913000695,-0.0166961267855093,0.0197084871107631,0.871165227707907
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32386,-0.00765534285917257,0.0119243198783367,-0.0310270098207124,0.0157163241023673,0.520894281956409
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32386,0.0246505833678541,0.0179381029302614,-0.0105080983754583,0.0598092651111665,0.169414990134797
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32386,0.00969184988417593,0.0167790046905944,-0.0231949993093891,0.042578699077741,0.563537515882786
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32386,0.0142838545948166,0.0204730986309323,-0.0258434187218107,0.0544111279114439,0.485390768159056
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32386,0.013135386991495,0.0199283998146491,-0.0259242766452173,0.0521950506282073,0.509830711433897
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32386,0.00302124881942579,0.0132342569108508,-0.0229178947258418,0.0289603923646934,0.819426254721557
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32386,0.0161432899485983,0.0124602463419449,-0.00827879288161373,0.0405653727788102,0.195154080937161
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32386,-0.000756668076286676,0.0154660555256392,-0.0310701369065394,0.0295568007539661,0.960980659356601
LYZL2,Lysozyme-like protein 2,Health and medical history,X120040.Fatigue severity over the past week,32394,0.0239156057815567,0.0570397831495352,-0.0878823691915324,0.135713580754646,0.675022509004329
LYZL2,Lysozyme-like protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32396,-0.0215552822559324,0.0565671532716962,-0.132426902668457,0.0893163381565922,0.703170799397639
LYZL2,Lysozyme-like protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32394,0.0842455930248408,0.0618801023959803,-0.0370394076712805,0.205530593720962,0.173412948384204
LYZL2,Lysozyme-like protein 2,Health and medical history,X120098.Mobility problems today,32398,0.0257442811368079,0.0695796479844639,-0.110631828912741,0.162120391186357,0.711393690636044
LYZL2,Lysozyme-like protein 2,Health and medical history,X120099.Self-care problems today,32398,-0.0257355036486586,0.107726101887441,-0.236878663348042,0.185407656050725,0.811190747950043
LYZL2,Lysozyme-like protein 2,Health and medical history,X120100.Problems doing usual activities,32398,-0.0167740353301797,0.0658206138398828,-0.14578243845635,0.112234367795991,0.798849180508142
LYZL2,Lysozyme-like protein 2,Health and medical history,X120101.Pain or discomfort today,32398,0.0352127489395137,0.0570336589280605,-0.0765732225594849,0.146998720438512,0.536985451364576
LYZL2,Lysozyme-like protein 2,Health and medical history,X120102.Anxiety or depression today,32398,-0.0497918343469408,0.0680645038167067,-0.183198261827686,0.0836145931338043,0.464470118217023
LYZL2,Lysozyme-like protein 2,Health and medical history,X120103.Scale to indicate how health is today,32369,0.00101665868271294,0.00399066724845827,-0.00680504912426526,0.00883836648969114,0.798915345237749
LYZL2,Lysozyme-like protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32382,-0.0290690881232155,0.0681048877570521,-0.162554668127038,0.104416491880607,0.669515234055761
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32369,-0.0764029479731487,0.0701523927025039,-0.213901637670056,0.0610957417237589,0.276140784940137
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32388,0.028563158682481,0.0563488106513391,-0.0818805101941437,0.139006827559106,0.612238760115323
LYZL2,Lysozyme-like protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32390,0.0407734314097522,0.0574289696602682,-0.0717873491243735,0.153334211943878,0.477735826612744
LYZL2,Lysozyme-like protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32385,-0.0298963386121901,0.0707793509993459,-0.168623866570908,0.108831189346528,0.672752592261324
LYZL2,Lysozyme-like protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32364,-0.032259100504267,0.07210431547224,-0.173583558829857,0.109065357821323,0.654601380291128
LYZL2,Lysozyme-like protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32391,0.0482831676232262,0.0718112766379066,-0.0924669345870708,0.189033269833523,0.501371534638073
LYZL2,Lysozyme-like protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32378,-0.0556276127021015,0.109875134371234,-0.27098287606972,0.159727650665517,0.612673017525848
LYZL2,Lysozyme-like protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32334,-0.213424325764589,0.148474005691248,-0.504433376919436,0.077584725390258,0.150626401670788
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",29949,0.0671225283405316,0.0733750568927962,-0.0766925831693489,0.210937639850412,0.360339838134024
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,44755,-0.0602931480751754,0.0785207424155417,-0.214193803209637,0.0936075070592864,0.442577446104297
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43642,-0.0221057871321503,0.047032487689993,-0.114289463004536,0.0700778887402359,0.638352331551565
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1289.Cooked vegetable intake,46527,-0.0338415146535587,0.0335235660278299,-0.0995477040681054,0.0318646747609879,0.312753188249166
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46093,-0.00770161440705528,0.0356810050065266,-0.0776363842198473,0.0622331554057368,0.829109504183606
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1309.Fresh fruit intake,46505,-0.0055901621530479,0.0352883348836153,-0.0747552985249339,0.0635749742188381,0.87413208750944
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1319.Dried fruit intake,45240,-0.0405114067132646,0.0374521911809349,-0.113917701427897,0.0328948880013678,0.279405512922613
LYZL2,Lysozyme-like protein 2,Health and medical history,X134.Number of self-reported cancers,47590,0.256854756483964,0.0659812239237685,0.127531557593378,0.386177955374551,9.93459264949777e-05
LYZL2,Lysozyme-like protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,47590,0.0318498974638732,0.0325704033812996,-0.031988093163474,0.0956878880912204,0.328144385097039
LYZL2,Lysozyme-like protein 2,Health and medical history,"X136.Number of operations, self-reported",47590,0.103251506654599,0.0325180427611733,0.0395161428426993,0.166986870466499,0.00149921185927359
LYZL2,Lysozyme-like protein 2,Health and medical history,X137.Number of treatments or medications taken,47590,0.0082225322405583,0.0323577400120827,-0.0551986381831238,0.0716437026642404,0.799410226971936
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1438.Bread intake,46853,0.00501433429294052,0.00257497584397921,-3.26183612587433e-05,0.0100612869471398,0.0515070346084976
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1458.Cereal intake,46183,0.0720824288891221,0.0337164755151415,0.00599813687944464,0.138166720898799,0.0325357465584395
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1488.Tea intake,46653,0.00345835389221732,0.00244467871493038,-0.00133321638904623,0.00824992417348087,0.157186103526992
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1498.Coffee intake,45638,-0.0458724680129839,0.0338283966251853,-0.112176125398347,0.0204311893723792,0.175102297486687
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1528.Water intake,45921,-0.0225178659879359,0.0347133456589847,-0.0905560234795459,0.0455202915036741,0.516551745950232
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1568.Average weekly red wine intake,39930,-0.0727423205928213,0.0400242864919738,-0.15118992211709,0.00570528093144725,0.0691661609308884
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,39927,-0.0489269173740244,0.0406604364908173,-0.128621372896026,0.0307675381479775,0.228875942431374
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,39969,0.0330428983039136,0.0445802501366313,-0.0543343919638837,0.120420188571711,0.458582758698268
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1598.Average weekly spirits intake,39904,0.0156900128483122,0.0443762394707785,-0.0712874165144137,0.102667442211038,0.723667396448836
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,39957,-0.0706989975515682,0.0829308652748901,-0.233243493490353,0.0918454983872165,0.393946414049822
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,42086,-0.0342442020428672,0.0389968504347351,-0.110678028894948,0.0421896248092136,0.379886172853885
LYZL2,Lysozyme-like protein 2,Health and medical history,X1807.Father's age at death,38058,0.00159879222506631,0.00343014190701981,-0.00512428591269252,0.00832187036282513,0.641150430574047
LYZL2,Lysozyme-like protein 2,Health and medical history,X1845.Mother's age,37376,-0.00652674717976157,0.00526734677067044,-0.0168507468502756,0.00379725249075249,0.215331544283303
LYZL2,Lysozyme-like protein 2,Health and medical history,X1873.Number of full brothers,47169,-0.0192064906854621,0.0322099733494987,-0.0823380384504794,0.0439250570795553,0.550987183431199
LYZL2,Lysozyme-like protein 2,Health and medical history,X1883.Number of full sisters,47168,0.00184670823460811,0.0322870876411564,-0.0614359835420585,0.0651294000112747,0.954389160785865
LYZL2,Lysozyme-like protein 2,Physical measures,X20015.Sitting height,47389,-0.0104591109917548,0.00326856457671896,-0.016865497562124,-0.00405272442138565,0.00137653055631667
LYZL2,Lysozyme-like protein 2,Cognitive function,X20016.Fluid intelligence score,31422,0.000911257096852348,0.0534551665135459,-0.103860869269698,0.105683383463402,0.986399468497454
LYZL2,Lysozyme-like protein 2,Cognitive function,X20018.Prospective memory result,31722,-0.146064948431566,0.0795812402703953,-0.302044179361541,0.00991428249840864,0.0664813345946155
LYZL2,Lysozyme-like protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31358,0.00160325606689121,0.00460802009427602,-0.0074284633178898,0.0106349754516722,0.727904536517137
LYZL2,Lysozyme-like protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31363,-0.00584901728567272,0.00455772802659313,-0.0147821642177953,0.00308412964644982,0.199420103708896
LYZL2,Lysozyme-like protein 2,Cognitive function,X20023.Mean time to correctly identify matches,47320,0.00298260325265237,0.00258962157315829,-0.00209305503073787,0.00805826153604261,0.249434508127749
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,44852,-0.00300571329141942,0.00565425538785845,-0.014088053851622,0.00807662726878315,0.595019578265805
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44485,-0.00320058220578764,0.0129969330305691,-0.028674570945703,0.0222734065341277,0.805485955049325
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44458,-0.00243453049736733,0.017312598856777,-0.0363672242566503,0.0314981632619156,0.888170023676795
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44486,0.00156697793829958,0.0131880431923276,-0.0242815867186624,0.0274155425952616,0.905420643447665
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44488,-0.000647275042130865,0.00968704614972516,-0.0196338854955922,0.0183393354113304,0.946726748591071
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,44623,0.00630076731145726,0.00744796966898813,-0.00829725323975948,0.020898787862674,0.397578599469576
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44573,0.00752345468091664,0.00973621088539904,-0.0115595186544655,0.0266064280162988,0.439691464911612
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44488,-0.0182773032348364,0.0117281284032423,-0.0412644349051913,0.00470982843551844,0.119150001414828
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44600,0.00843118642966523,0.00922851029935062,-0.00965669375706197,0.0265190666163924,0.360936580514305
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44721,0.00537114903093166,0.00587250676202781,-0.00613896422264284,0.0168812622845062,0.360398427353088
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44596,0.00981757477118737,0.00797483093685562,-0.00581309386504965,0.0254482434074244,0.218310663779407
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45728,-0.00656971052239773,0.00675191702875358,-0.0198034678987547,0.00666404685395929,0.330557053053019
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45626,-0.00425157853415358,0.0109399393465629,-0.0256938596534168,0.0171907025851096,0.697554355037779
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45574,-0.0138186888684334,0.023611655778118,-0.0600975341935447,0.0324601564566779,0.558386641407839
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45613,0.0125671436410207,0.00982917492605078,-0.0066980392140388,0.0318323264960802,0.201067342020844
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,45678,-0.0095767940968779,0.00802569206893395,-0.0253071505519884,0.00615356235823263,0.232777768266543
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45620,0.00946255783825897,0.0131296971246353,-0.0162716485260263,0.0351967642025443,0.471102551901874
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45599,0.00863925188864144,0.012315986722753,-0.0155000820879543,0.0327785858652372,0.483019453599836
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45626,0.00830824949141062,0.00939792624400946,-0.0101116859468479,0.0267281849296692,0.376678252233721
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45635,0.00745727050476647,0.0110464220662527,-0.0141937167450888,0.0291082577546217,0.499629122913418
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45824,-0.00890885427150458,0.00530512869935205,-0.0193069065222346,0.00148919797922543,0.0931095897329005
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45681,-0.00648570708988455,0.00822000320579958,-0.0225969133732517,0.00962549919348262,0.430111722271625
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43329,-0.0074191076023826,0.0108756354004179,-0.0287353529872017,0.0138971377824365,0.495135194234132
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43237,0.0564133003636952,0.064590937168779,-0.0701849364871116,0.183011537214502,0.382459492477408
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43236,-0.0850586217587578,0.0508300145468556,-0.184685450270595,0.0145682067530792,0.0942659761655448
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43309,0.00416716283854051,0.010039746808714,-0.0155107409065389,0.02384506658362,0.678097781125014
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43240,0.0310651905493997,0.0342013150355982,-0.0359693869203727,0.0980997680191721,0.363728935166469
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43255,0.0121419233001195,0.0186752774906766,-0.0244616205816066,0.0487454671818456,0.515596407566345
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43241,0.0283315374123207,0.0245857009542761,-0.0198564364580605,0.0765195112827019,0.24918806823558
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43252,0.041939995421022,0.0223357834561876,-0.00183814015310575,0.0857181309951497,0.0604366314527925
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43252,0.0113176830253135,0.0149310807420863,-0.0179472352291757,0.0405826012798028,0.448463248173863
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43258,0.0230987875469198,0.0197929328700423,-0.015695360878363,0.0618929359722027,0.243215842291009
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43409,-0.00302011238997104,0.00699956966370525,-0.0167392689308333,0.0106990441508912,0.666130581629411
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43317,0.00164987258231009,0.0102007799667201,-0.0183436561524612,0.0216434013170814,0.87151240435216
LYZL2,Lysozyme-like protein 2,Mental health,X20127.Neuroticism score,42855,-0.0329857374692,0.0335586967445899,-0.0987607830885962,0.0327893081501963,0.325656065432509
LYZL2,Lysozyme-like protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31422,-0.0228834547446618,0.0546917996229652,-0.130079382005674,0.0843124725163501,0.675661161939765
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20161.Pack years of smoking,30508,-0.00830653937434971,0.00530199509123035,-0.0186984497531612,0.00208537100446179,0.117236674452038
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30508,-0.00806046995667196,0.00495550488670192,-0.0177732595346077,0.00165231962126381,0.103876090814572
LYZL2,Lysozyme-like protein 2,Cognitive function,X20191.Fluid intelligence score,29932,-0.0280990165709844,0.0602799313089133,-0.146247681936454,0.0900496487944857,0.641130511224813
LYZL2,Lysozyme-like protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,29932,0.0453970278289524,0.0626138750347475,-0.0773261672391526,0.168120222897057,0.468460738131509
LYZL2,Lysozyme-like protein 2,Cognitive function,X20240.Maximum digits remembered correctly,29390,-0.142753635661567,0.0644949554149442,-0.269163748274858,-0.0163435230482767,0.0269102721393773
LYZL2,Lysozyme-like protein 2,Physical measures,X20255.Spirometry QC measure,41468,0.0129844211635598,0.042509050054605,-0.070333316943466,0.0963021592705857,0.760026485734795
LYZL2,Lysozyme-like protein 2,Eye measures,X20261.avMSE,29043,0.000314009373758209,0.00566393806957056,-0.0107873092426001,0.0114153279901165,0.955789975270949
LYZL2,Lysozyme-like protein 2,Eye measures,X20262.Myopia diagnosis,29043,-0.000448627504687525,0.0791800465370991,-0.155641518717402,0.154744263708027,0.995479495263185
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20280.Glucose-lactate,36932,0.006707730726014,0.00334965620727446,0.000142404559756054,0.013273056892272,0.0452501820483743
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,36958,0.00677163603783542,0.00330399098751166,0.00029581370231257,0.0132474583733583,0.0404299716554695
LYZL2,Lysozyme-like protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31238,0.0143002253309837,0.0162404527071787,-0.0175310619750865,0.0461315126370539,0.378600291057993
LYZL2,Lysozyme-like protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31236,0.0181626011440766,0.032660956331975,-0.0458528732665945,0.0821780755547477,0.578162642331685
LYZL2,Lysozyme-like protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31236,-0.0191883866365409,0.0365233465301671,-0.0907741458356685,0.0523973725625867,0.599339587548959
LYZL2,Lysozyme-like protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31236,0.00825376454391825,0.0156978866991558,-0.0225140933864271,0.0390216224742636,0.599051138381288
LYZL2,Lysozyme-like protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31236,-0.0100479713971068,0.024740479320253,-0.0585393108648028,0.0384433680705891,0.684655286253468
LYZL2,Lysozyme-like protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31240,-0.0249003015678487,0.0320964738556488,-0.0878093903249204,0.038008787189223,0.437894571652844
LYZL2,Lysozyme-like protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31240,-0.00352159231310396,0.0216574453279342,-0.045970185155855,0.0389270005296471,0.870834504775107
LYZL2,Lysozyme-like protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31240,-0.0255365163752956,0.0234568869414314,-0.0715120147805012,0.0204389820299099,0.276340490139971
LYZL2,Lysozyme-like protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31240,0.0629658504048779,0.0362524036823343,-0.00808886081249732,0.134020561622253,0.0824511720585408
LYZL2,Lysozyme-like protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31240,0.0524503063276249,0.0411981215445663,-0.0282980118997251,0.133198624554975,0.203014239441111
LYZL2,Lysozyme-like protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31240,-0.00117432000566047,0.0242830855895788,-0.0487691677612349,0.046420527749914,0.961430974589517
LYZL2,Lysozyme-like protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31240,0.0766049915310884,0.0402685720541291,-0.00232140969500465,0.155531392757181,0.0571640638719221
LYZL2,Lysozyme-like protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31240,0.0405239725314415,0.0302542448015016,-0.0187743472795016,0.0998222923423845,0.180466282000971
LYZL2,Lysozyme-like protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31243,0.013074909381718,0.0422323034897392,-0.069700405458171,0.0958502242216069,0.756877707309914
LYZL2,Lysozyme-like protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31243,0.0204586250750417,0.0210360765595646,-0.020772084981705,0.0616893351317883,0.33080912891186
LYZL2,Lysozyme-like protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31243,0.0138294594494127,0.0284441350663257,-0.0419210452805856,0.0695799641794111,0.6268417711114
LYZL2,Lysozyme-like protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31243,0.0133645273283663,0.0479153556066592,-0.0805495696606857,0.107278624317418,0.780314410517205
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,33120,-0.052098105957249,0.0502430224176667,-0.150574429895876,0.0463782179813777,0.299799213556862
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20601.Liking for aniseed,33120,-0.0321671329039028,0.0502729940225527,-0.130702201188106,0.0663679353803004,0.522286515211562
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20602.Liking for apple juice,33120,0.00177471107189223,0.0502144902104059,-0.0966456897405034,0.100195111884288,0.971807310341525
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20603.Liking for apples,33120,0.0774929536401774,0.0514002340279464,-0.0232515050545975,0.178237412334952,0.131681310596089
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20604.Liking for asparagus,33120,-0.0924488398208003,0.0515096701975352,-0.193407793407969,0.00851011376636882,0.0727204205297086
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20605.Liking for aubergine,33120,-0.0727972415764187,0.0511644437137565,-0.173079551255381,0.0274850681025441,0.15482519066863
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20606.Liking for avocados,33120,0.0867190253968421,0.0517279145179399,-0.0146676870583202,0.188105737852004,0.0936847671690565
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20607.Liking for bacon,33120,0.0140173851157923,0.0512886477787498,-0.0865083645305573,0.114543134762142,0.784625753773753
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,33120,0.0714274298446639,0.0509411231920391,-0.0284171716117328,0.171272031301061,0.16090205473716
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20609.Liking for bananas,33120,0.085396994669555,0.0520792717017409,-0.0166783778658572,0.187472367204967,0.101091123171696
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33120,-0.00219281732361743,0.0506905597201573,-0.101546314375126,0.0971606797278908,0.965496095531942
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20611.Liking for beef steak,33120,0.0181217137501464,0.0505902264443107,-0.0810351300807026,0.117278557580995,0.720197462160565
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20612.Liking for beetroot,33120,0.0994439803535561,0.0517574913991354,-0.00200070278874921,0.200888663495861,0.0547189600726266
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20613.Liking for bell pepper,33120,0.0391315287546765,0.0510361089546091,-0.0608992447963574,0.13916230230571,0.443254486580732
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20614.Liking for bicycling,33120,0.0517088080436863,0.0501436528408081,-0.0465727515242975,0.14999036761167,0.302467704490273
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20615.Liking for biscuits,33120,0.0411517713098501,0.0503894636573628,-0.0576115774585811,0.139915120078281,0.414135709488115
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20616.Liking for bitter foods,33120,0.0305546915904479,0.0501046825406791,-0.0676504861892832,0.128759869370179,0.54199795848842
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20617.Liking for bitter or ale,33120,0.00151238516141935,0.0512847457667505,-0.0990057165414116,0.10203048686425,0.976474461418233
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20618.Liking for black olives,33120,0.0392648420097355,0.050742598957199,-0.0601906519463746,0.138720335965846,0.439066293857798
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20619.Liking for black pepper,33120,0.00263630590827685,0.0513461103830935,-0.0980020704425864,0.10327468225914,0.959052652218771
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20620.Liking for blue cheese,33120,-0.062338142792863,0.0504265342189522,-0.161174149862009,0.0364978642762833,0.2164092704421
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,33120,0.113277028132581,0.0508243979461713,0.0136612081580847,0.212892848107076,0.0258516549020204
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20622.Liking for broad beans,33120,0.128476760969947,0.0508712183092804,0.0287691730837569,0.228184348856136,0.0115689704086551
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20623.Liking for broccoli,33120,0.0286572821337405,0.0522685028178961,-0.0737889833893358,0.131103547656817,0.583519357784374
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20624.Liking for brown rice,33120,0.0974970473111768,0.0508329336811436,-0.0021355027038647,0.197129597326218,0.0551430579766062
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,33120,0.0583137082364435,0.0515170144310791,-0.0426596400484716,0.159287056521359,0.257692762859571
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20626.Liking for burgers (meat),33120,0.0325960181137418,0.0500472024834651,-0.0654964987538498,0.130688534981333,0.514865478298368
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,33120,-0.0671245262001287,0.0506447956443485,-0.166388325663052,0.0321392732627944,0.185071810172258
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20628.Liking for butter on bread,33120,0.0426457062589258,0.051244355572704,-0.0577932306635741,0.143084643181426,0.405315854446095
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20629.Liking for butternut squash,33120,0.073013253109422,0.0512306314866807,-0.0273987846044721,0.173425290823316,0.1541367593263
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20630.Liking for cabbage,33120,-0.00873990167087594,0.05127333044521,-0.109235629343487,0.0917558260017356,0.864654421093919
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20631.Liking for cake,33120,-0.00985286501816133,0.0505501595265622,-0.108931177690223,0.0892254476539005,0.845465619364241
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20632.Liking for cake icing,33120,-0.00502392563847333,0.0498104759032867,-0.102652458408915,0.0926046071319686,0.919663128184867
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20633.Liking for capers,33120,0.00195825016266688,0.0501955632599768,-0.0964250538268877,0.100341554152221,0.96888133194959
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20634.Liking for cauliflower,33120,0.0450153533191719,0.0520002472970718,-0.0569051313830888,0.146935838021433,0.386690448430585
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,33120,0.0240204869330696,0.0503918839287845,-0.074747605567348,0.122788579433487,0.633605735682127
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20636.Liking for cheesecake,33120,0.0712471251862929,0.050647709748569,-0.0280223859209024,0.170516636293488,0.159544148043429
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20637.Liking for cherries,33120,0.0555138611806558,0.0529727281829229,-0.0483126860578732,0.159340408419185,0.294679535520372
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20638.Liking for chicken,33120,0.0295972511495806,0.0528200513331558,-0.0739300494634047,0.133124551762566,0.575260296610442
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20639.Liking for chilli pepper,33120,-0.0544434658604369,0.0509032815013893,-0.15421389760316,0.0453269658822861,0.28485104540139
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20640.Liking for chips or french fries,33120,0.0568484007041875,0.0513041951267482,-0.0437078217442389,0.157404623152614,0.267862403500605
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,33120,0.0573321630757596,0.0788922297714723,-0.0972966072763261,0.211960933427845,0.467418978743322
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20642.Liking for cod,33120,0.0872641451855969,0.0516396201607866,-0.0139495103295449,0.188477800700739,0.0910868909458595
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,33120,-0.0784446739387138,0.0548760213214276,-0.186001675728712,0.0291123278512842,0.152897475140071
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,33120,0.0300682084363772,0.0510415202973028,-0.0699731713463363,0.130109588219091,0.555813192750278
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20645.Liking for coriander,33120,-0.0492779944645036,0.0505036736962154,-0.148265194909086,0.0497092059800785,0.329223353772169
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20646.Liking for corn flakes,33120,0.0619403075267364,0.0499512023891393,-0.0359640491559766,0.159844664209449,0.21500079932274
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20647.Liking for cream,33120,0.0188497552732694,0.0506321082849782,-0.0803891769652879,0.118088687511827,0.709686534433194
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20648.Liking for croissant,33120,0.00251374994430323,0.0505307467536652,-0.0965265136928806,0.101554013581487,0.960325125293023
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20649.Liking for cucumber,33120,0.0538072738615676,0.0509777474383491,-0.0461091111175966,0.153723658840732,0.291221929156054
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20650.Liking for curry,33120,0.00396818030303766,0.0519054937105547,-0.0977665873696496,0.105702947975725,0.939062663546689
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20651.Liking for dairy products,33120,0.0642615351519605,0.0513157428161656,-0.0363173207677241,0.164840391071645,0.210500528473563
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20652.Liking for dark chocolate,33120,-0.0413397323914874,0.0509612670457531,-0.141223815801163,0.0585443510181887,0.417272229614428
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33120,0.0690468886244359,0.0516038537178292,-0.0320966646625093,0.170190441911381,0.180923434936049
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20654.Liking for dried fruit,33120,0.106929659888684,0.0505542127876482,0.00784340282489392,0.206015916952475,0.0344439663036248
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20655.Liking for eggs,33120,0.106852637408114,0.0521383212487592,0.00466152776054618,0.209043747055682,0.0404504791482957
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20656.Liking for exercising alone,33120,0.0498761487254105,0.0500887183226194,-0.0482977391869234,0.148050036637745,0.319394690679146
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20657.Liking for exercising with others,33120,0.0046523707969394,0.0496517719426654,-0.0926651022106848,0.101969843804564,0.9253495031774
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33120,0.0577007438171269,0.0508983594910197,-0.0420600407852717,0.157461528419526,0.256972263267201
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20659.Liking for fatty foods,33120,-0.0340668540413437,0.0506689426658585,-0.133377981666426,0.0652442735837389,0.501382842004108
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,33120,0.042002573625064,0.0542213861241432,-0.0642713431782567,0.148276490428385,0.438566553878236
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20661.Liking for fried chicken,33120,-0.0155504505200819,0.0500472062255598,-0.113642974722179,0.0825420736820153,0.756023794313503
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,33120,0.0184367056107252,0.0507625193665378,-0.0810578323476889,0.117931243569139,0.716467338480473
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20663.Liking for fruit,33120,0.0658569411024514,0.0558132547518322,-0.0435370382111397,0.175250920416042,0.238049792836985
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20664.Liking for garlic,33120,0.08102177583165,0.0512075516092925,-0.0193450253225633,0.181388576985863,0.113632812202379
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20665.Liking for gherkins,33120,-0.0349207001783735,0.0504171314298443,-0.133738277780868,0.0638968774241214,0.48855564799517
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20666.Liking for globe artichoke,33120,0.0118570491568574,0.0501331187916829,-0.0864038636748412,0.110117961988556,0.813041175294628
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20667.Liking for goat's cheese,33120,0.101447493867452,0.0503415986087274,0.00277796059434668,0.200117027140558,0.0439144302984781
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20668.Liking for going to a cafe,33120,-0.0150206640685985,0.0507705835186867,-0.114531007765224,0.0844896796280274,0.767348465208638
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20669.Liking for going to the gym,33120,0.0202388326790853,0.0492372102852321,-0.0762660994799695,0.11674376483814,0.681047218971383
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20670.Liking for going to the pub,33120,-0.0382551405181154,0.0501931296559812,-0.136633674643839,0.0601233936076078,0.445984603101274
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20671.Liking for grapefruit,33120,-0.0519598640341432,0.0501287791216617,-0.1502122711126,0.0462925430443138,0.299983154120774
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20672.Liking for green olives,33120,0.0165069719948874,0.0506895658405967,-0.0828445770526822,0.115858521042457,0.744697813685037
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20673.Liking for haddock,33120,0.0130099732247208,0.0515957433832912,-0.0881176838065299,0.114137630255972,0.800929129513664
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20674.Liking for ham,33120,0.0514076052718811,0.0506489715560842,-0.0478643789780439,0.150679589521806,0.310142732568266
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20675.Liking for hard cheese,33120,0.0913453813520887,0.0521132958231558,-0.0107966784612967,0.193487441165474,0.0796655232633384
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20676.Liking for herring,33120,-0.0492764811011696,0.0499712715019619,-0.147220173245015,0.0486672110426757,0.324111695918103
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20677.Liking for honey,33120,0.0164669084229473,0.0499578823406103,-0.081450540964649,0.114384357810544,0.741697729049364
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33120,-0.105871120383522,0.0503074426541124,-0.204473707985582,-0.00726853278146183,0.0353633080442556
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20679.Liking for ice cream,33120,-0.0238996278037378,0.0511923530042776,-0.124236639692122,0.0764373840846463,0.640611516456286
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20680.Liking for jam,33120,0.0806825492505979,0.0500564515789009,-0.0174280958440478,0.178793194345244,0.10703279473406
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,33120,0.0399996173993196,0.049771321002398,-0.0575521717653805,0.13755140656402,0.421609396061487
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20682.Liking for lager,33120,-0.0212073659284963,0.0499734666094886,-0.119155360483094,0.0767406286261014,0.67130402713296
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20683.Liking for lamb,33120,0.0113081201448365,0.0513653484815945,-0.0893679628790887,0.111984203168762,0.825758606859333
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20684.Liking for lemons,33120,-0.00714681540202655,0.0509715574473741,-0.10705106799888,0.0927574371948266,0.888495676911671
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20685.Liking for lentils or beans,33120,0.0398209397542822,0.0511056131729407,-0.0603460620646815,0.139987941573246,0.435888226648358
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20686.Liking for liver,33120,0.0369331176069135,0.0511530913824141,-0.0633269415026181,0.137193176716445,0.470305687947299
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20687.Liking for mackerel,33120,0.019789276680232,0.0506534049107376,-0.0794913969448137,0.119069950305278,0.696042715116285
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20688.Liking for marzipan,33120,0.0790212689327869,0.0506550168193718,-0.0202625640331818,0.178305101898756,0.118796687635658
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20689.Liking for mayonnaise,33120,0.189193839521207,0.0509528031291593,0.0893263453880547,0.289061333654359,0.000205923394976636
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20690.Liking for melon,33120,-0.0345824253418875,0.0520586923848251,-0.136617462416145,0.0674526117323698,0.506516893654483
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20691.Liking for milk chocolate,33120,0.0530397167615624,0.0505205162268231,-0.0459804950430108,0.152059928566136,0.29380765591646
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20692.Liking for mushrooms,33120,0.12411537925451,0.0527440073777202,0.0207371247941781,0.227493633714841,0.0186351624912223
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20694.Liking for orange juice,33120,0.0106284921275588,0.0501285757127137,-0.0876235162693601,0.108880500524478,0.832092499327683
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20695.Liking for oranges,33120,-0.0804849473005868,0.051397083275901,-0.181223230521353,0.0202533359201791,0.117395962542728
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20696.Liking for pasta,33120,0.12429246130928,0.0510044865986469,0.0243236675759316,0.224261255042628,0.0148327970462622
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20697.Liking for pears,33120,0.120918026919157,0.0515194317353892,0.0199399407177941,0.22189611312052,0.0189443314679963
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20698.Liking for pizza,33120,0.0302662828377013,0.0504939175709757,-0.068701795601411,0.129234361276814,0.54891783709241
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20699.Liking for plain yogurt,33120,0.0358664663987842,0.0502869154239475,-0.0626958878321529,0.134428820629721,0.475717379704021
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20700.Liking for plums,33120,0.0400473365473392,0.051839604160394,-0.0615582876070331,0.141652960701712,0.439823894262662
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20701.Liking for pollock,33120,-0.0111951867915498,0.0504716334327748,-0.110119588319788,0.0877292147366887,0.824465552505969
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20702.Liking for pork chop,33120,0.0425340432452164,0.0501350577867139,-0.0557306700167429,0.140798756507176,0.396243187502642
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20703.Liking for porridge,33120,0.12466964291291,0.0511254376571588,0.0244637851048784,0.224875500720941,0.0147668314993765
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20704.Liking for potato crisps,33120,-0.0390024634837742,0.0509136674237446,-0.138793251634314,0.0607883246667653,0.443665529879329
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20705.Liking for potatoes,33120,0.033251617761981,0.0513907373994418,-0.067474227540925,0.133977463064887,0.51762519272672
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20706.Liking for prawns,33120,0.0775911712255834,0.0517175073587308,-0.023775143197529,0.178957485648696,0.133573864782302
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20707.Liking for raw carrots,33120,0.0546733894754362,0.0507619504881294,-0.0448200334812974,0.15416681243217,0.281483983816225
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20708.Liking for red meat,33120,-0.00882473651445552,0.0503208465273793,-0.107453595708119,0.0898041226792079,0.860793223640312
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20709.Liking for red wine,33120,-0.0274316427560984,0.0509778437884117,-0.127348216581385,0.0724849310691886,0.590514660760034
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33120,-0.059701068416607,0.0516584248623699,-0.160951581146852,0.041549444313638,0.247838275036804
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20711.Liking for roast chicken,33120,0.0363304647280611,0.0532079622056494,-0.0679571411950118,0.140618070651134,0.494749518117266
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20712.Liking for salad dressing,33120,0.0929083523034384,0.0503638552856431,-0.00580480405642202,0.191621508663299,0.0651069286842268
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20713.Liking for salad leaves,33120,0.0675520616341104,0.0518904321336417,-0.0341531853478273,0.169257308616048,0.19300994910632
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20714.Liking for salami,33120,-0.000683038940850702,0.0506080449975736,-0.0998748071360949,0.0985087292543935,0.989231851355509
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20715.Liking for salmon,33120,0.0269448948521687,0.05269998497669,-0.0763470757021436,0.130236865406481,0.609161277552338
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20716.Liking for salty foods,33120,0.0574738843163987,0.0501601170635283,-0.0408399451281167,0.155787713760914,0.251904070289917
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20717.Liking for salty pretzels,33120,0.0054083825255772,0.0497839769038344,-0.0921682122059383,0.102984977257093,0.913492758790117
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20718.Liking for sardines,33120,0.0304802915629717,0.0504378837756942,-0.0683779606373888,0.129338543763332,0.545650085409379
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20719.Liking for sausages (meat),33120,0.0468595216342568,0.0501691007453799,-0.0514719158266878,0.145190959095201,0.350312010176142
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,33120,0.0714660872241899,0.0512207407029881,-0.0289265645536667,0.171858739002047,0.162971903924488
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33120,-0.00147503309929625,0.0510330326017892,-0.101499776998803,0.0985497108002105,0.976942180142623
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20722.Liking for skimmed milk,33120,0.117761492888223,0.0503822561554896,0.0190122708234639,0.216510714952983,0.0194416633637421
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20723.Liking for smoked fish,33120,-0.0240090810877985,0.0508079789619224,-0.123592719853166,0.0755745576775694,0.636548630530215
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20724.Liking for soft cheese,33120,0.0195977302853629,0.0503999909221651,-0.0791862519220807,0.118381712492807,0.697400554492314
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20725.Liking for soy sauce,33120,0.055126648145203,0.0504212912609041,-0.043699082726169,0.153952379016575,0.274281427613779
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20726.Liking for soya milk,33120,0.0838672356337578,0.0506729686586797,-0.0154517829372545,0.18318625420477,0.0979445189421483
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20727.Liking for spicy foods,33120,-0.0233392651052641,0.0513152236042197,-0.123917103369535,0.0772385731590065,0.64924835991869
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20728.Liking for spinach,33120,0.0116697613320646,0.0508713029351001,-0.0880379924207315,0.111377515084861,0.818564872911929
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20729.Liking for spirits,33120,0.035817592620143,0.0496431505030516,-0.0614829823658382,0.133118167606124,0.470619437237237
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20730.Liking for strawberries,33120,-0.0164961369852087,0.0544935765396194,-0.123303547002863,0.0903112730324453,0.762112277743004
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33120,0.0339957805225818,0.051450280876044,-0.0668467699944644,0.134838331039628,0.508789013246656
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20732.Liking for sweet foods,33120,0.0279857217313871,0.0499889068757478,-0.0699925357450786,0.125963979207853,0.57560305848571
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20733.Liking for taking the stairs,33120,0.105718550512408,0.0517694872411842,0.00425035551968742,0.20718674550513,0.0411697566544683
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20734.Liking for tea with sugar,33120,-0.116256445653134,0.0614545812290703,-0.236707424862112,0.00419453355584404,0.0585560619419325
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20735.Liking for tea without sugar,33120,0.130004644076722,0.0532098005094218,0.025713435078255,0.234295853075188,0.0145743682583123
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,33120,0.0803429859891841,0.049920755502572,-0.017501694795857,0.178187666774225,0.107560740521042
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20737.Liking for tinned tuna,33120,0.0826064525426304,0.050856579189718,-0.0170724426692168,0.182285347754478,0.104345399782773
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20738.Liking for turnip (white),33120,0.0154423073689039,0.0497515269214968,-0.0820706853972298,0.112955300135038,0.756272445617072
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20739.Liking for vegetables,33120,0.0639873252378648,0.0561872099150542,-0.0461396061956415,0.174114256671371,0.254806191352561
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20740.Liking for vinegar,33120,-0.0622723210431671,0.0504112390592883,-0.161078349599372,0.036533707513038,0.216755281214989
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20741.Liking for watching television,33120,0.0708891442034332,0.0512355377913697,-0.0295325098676515,0.171310798274518,0.166516420378906
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20742.Liking for whisky,33120,0.0852438166944053,0.0519837185321791,-0.0166442716286657,0.187131905017476,0.101077097330477
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20743.Liking for white bread,33120,0.000925518253179972,0.049971844963168,-0.0970192978746293,0.0988703343809892,0.985223788498559
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20744.Liking for white rice,33120,0.0465133813689005,0.0501421027031541,-0.0517651399292816,0.144791902667083,0.353623083044821
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20745.Liking for white wine,33120,-0.0242111785830122,0.0502754002076414,-0.122750962989989,0.0743286058239649,0.630122068328571
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33120,0.0717135477001688,0.0511889237157494,-0.0286167427826999,0.172043838183038,0.161260085166894
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20747.Liking for whole milk,33120,-0.0429142204520628,0.0498196781176001,-0.140560789562559,0.0547323486584334,0.389045077988279
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,33120,0.0668085536437374,0.0522523167991958,-0.0356059872826864,0.169223094570161,0.201078511403777
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20749.Liking for working up a sweat,33120,0.0872142681714438,0.050067191691465,-0.0109174275438276,0.185345963886715,0.0815513948963152
LYZL2,Lysozyme-like protein 2,Physical measures,X21001.Body mass index (BMI),47475,0.0288752702742827,0.0103027877890198,0.00868180620780385,0.0490687343407616,0.00507234598494741
LYZL2,Lysozyme-like protein 2,Physical measures,X21002.Weight,47494,-0.00872553122532168,0.00601957386561957,-0.020523896001936,0.00307283355129268,0.147203902416732
LYZL2,Lysozyme-like protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,31653,0.00552850536081015,0.00471637140203549,-0.0037155825871794,0.0147725933087997,0.241154745487239
LYZL2,Lysozyme-like protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32659,0.0235274654266289,0.0535669701019582,-0.0814637959732091,0.128518726826467,0.660515890681001
LYZL2,Lysozyme-like protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32659,-0.0108864556499231,0.0558972346306391,-0.120445035525976,0.0986721242261296,0.845586593194726
LYZL2,Lysozyme-like protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32659,0.0282283183349486,0.054525553540129,-0.0786417666037042,0.135098403273601,0.604674996155528
LYZL2,Lysozyme-like protein 2,Health and medical history,X21040.Satisfaction with bowel habits,32632,0.00353432581411662,0.0509112465151553,-0.0962517173555878,0.103320368983821,0.944655844855857
LYZL2,Lysozyme-like protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32631,-0.00413384999512173,0.0536407359901075,-0.109269692535732,0.101001992545489,0.938573200096389
LYZL2,Lysozyme-like protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,32625,-0.109583592821686,0.0547033686299822,-0.216802195336451,-0.00236499030692076,0.0451830205020835
LYZL2,Lysozyme-like protein 2,Health and medical history,X21043.Least number of times bowels opened per week,32572,0.0291615916981299,0.0545428223514512,-0.0777423401107143,0.136065523506974,0.592902102249077
LYZL2,Lysozyme-like protein 2,Health and medical history,X21044.Average number of times bowels opened per day,32609,-0.0570478340622049,0.0610521836447211,-0.176710114005858,0.0626144458814484,0.35011771967469
LYZL2,Lysozyme-like protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32663,0.0105362803385247,0.0551521935599267,-0.0975620190389317,0.118634579715981,0.848498585906628
LYZL2,Lysozyme-like protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32657,-0.0563005925867554,0.0554953301467882,-0.16507143967446,0.0524702545009495,0.310367148229282
LYZL2,Lysozyme-like protein 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29008,-0.0643273471235566,0.0821982621859804,-0.225435941008078,0.0967812467609649,0.433905282526724
LYZL2,Lysozyme-like protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32661,0.0369764265721076,0.058561073928779,-0.0778032783282993,0.151756131472514,0.527784650191713
LYZL2,Lysozyme-like protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32658,-0.00506320695021189,0.0825554706477328,-0.166871929419768,0.156745515519344,0.951097021371685
LYZL2,Lysozyme-like protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32661,0.0281650405069292,0.0664915058480927,-0.102158310955333,0.158488391969191,0.67187626009273
LYZL2,Lysozyme-like protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32660,0.26277548701294,0.17428295518147,-0.0788191051427418,0.604370079168622,0.13165389387958
LYZL2,Lysozyme-like protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32662,-0.0134758980934162,0.0620558194736504,-0.135105304261771,0.108153508074938,0.828090494022845
LYZL2,Lysozyme-like protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32661,0.055263241040909,0.0654122499207669,-0.0729447688037941,0.183471250885612,0.398220108469038
LYZL2,Lysozyme-like protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32450,0.0559985675289375,0.0575818755063597,-0.0568619084635275,0.168859043521403,0.33082758274068
LYZL2,Lysozyme-like protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32661,-0.0296281980845968,0.0572296192607544,-0.141798251835675,0.0825418556664818,0.604675439641479
LYZL2,Lysozyme-like protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32662,0.0521952488196344,0.0793624185309653,-0.103355091501057,0.207745589140326,0.510759572565713
LYZL2,Lysozyme-like protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32661,-0.0597414446729682,0.0546952687836365,-0.166944171488896,0.0474612821429593,0.274748815247925
LYZL2,Lysozyme-like protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32660,-0.0986891399009189,0.0556928379522025,-0.207847102287236,0.0104688224853979,0.0764248913793439
LYZL2,Lysozyme-like protein 2,Working and living environment,X21100.Water hardness (USGS classification),47277,0.131136020456685,0.032867663896925,0.0667153992187118,0.195556641694658,6.63249467147841e-05
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,44959,0.000750802882611746,0.00277546996265059,-0.0046891182441834,0.0061907240094069,0.78676765979579
LYZL2,Lysozyme-like protein 2,Health and medical history,X2149.Lifetime number of sexual partners,43272,-0.0219371389609454,0.0370175153682372,-0.0944914690826904,0.0506171911607996,0.553445667549255
LYZL2,Lysozyme-like protein 2,Physical activities,X22032.IPAQ activity group,43245,-0.0133908293612481,0.0359102328046052,-0.0837748856582743,0.0569932269357781,0.709228948415062
LYZL2,Lysozyme-like protein 2,Physical activities,X22033.Summed days activity,43735,-0.00445213120661229,0.00265806065312722,-0.00966193008674164,0.000757667673517055,0.0939588502752152
LYZL2,Lysozyme-like protein 2,Physical activities,X22034.Summed minutes activity,43245,0.000722117208984762,0.00271989149824455,-0.00460887012757455,0.00605310454554408,0.790631093173413
LYZL2,Lysozyme-like protein 2,Physical activities,X22037.MET minutes per week for walking,42592,-0.00227404237574161,0.00268716147917613,-0.00754087887492682,0.0029927941234436,0.397417468288637
LYZL2,Lysozyme-like protein 2,Physical activities,X22038.MET minutes per week for moderate activity,43245,0.000439579642914981,0.00278907446257283,-0.00502700630372777,0.00590616558955774,0.874767568261927
LYZL2,Lysozyme-like protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,43245,-0.0131726595114235,0.0356894430137983,-0.0831239678184683,0.0567786487956212,0.712063775961447
LYZL2,Lysozyme-like protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,42592,-0.00317176971977786,0.00275979332091246,-0.00858096462876629,0.00223742518921057,0.250456044786674
LYZL2,Lysozyme-like protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,42777,0.00220398855087351,0.00315685956612605,-0.00398345619873354,0.00839143330048056,0.485086616312516
LYZL2,Lysozyme-like protein 2,Working and living environment,X22501.Year ended full time education,29887,-0.0048600397413061,0.013266462977015,-0.0308623071762556,0.0211422276936434,0.714124036428899
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X22506.Tobacco smoking,29846,0.18457206374671,0.131509961955823,-0.0731874616867029,0.442331589180124,0.160524592732007
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,45871,-0.0219640510042731,0.071804166335999,-0.162700217022831,0.118772115014285,0.759692623235176
LYZL2,Lysozyme-like protein 2,Physical measures,X23098.Weight,47167,-0.0074524164758552,0.00606244432825655,-0.019334807359238,0.00442997440752764,0.218980804237151
LYZL2,Lysozyme-like protein 2,Physical measures,X23099.Body fat percentage,47146,0.00810553713245772,0.00586269860536978,-0.00338535213406706,0.0195964263989825,0.166812841952217
LYZL2,Lysozyme-like protein 2,Physical measures,X23100.Whole body fat mass,47116,0.00208693995136856,0.0055777180149992,-0.00884538735802986,0.013019267260767,0.708291229676156
LYZL2,Lysozyme-like protein 2,Physical measures,X23101.Whole body fat-free mass,47163,-0.0148025366036212,0.00517188795841015,-0.0249394370021051,-0.00466563620513733,0.00421199405884826
LYZL2,Lysozyme-like protein 2,Physical measures,X23102.Whole body water mass,47167,-0.0149317255350111,0.00517084176407836,-0.0250665753926047,-0.00479687567741752,0.00388454007716684
LYZL2,Lysozyme-like protein 2,Physical measures,X23104.Body mass index (BMI),47167,0.0328887416973008,0.0103891004098094,0.0125261048940745,0.0532513785005272,0.00154911089619889
LYZL2,Lysozyme-like protein 2,Physical measures,X23105.Basal metabolic rate,47165,-0.0146815104157815,0.00554253026913363,-0.0255448697432834,-0.00381815108827957,0.00808128876864076
LYZL2,Lysozyme-like protein 2,Physical measures,X23106.Impedance of whole body,47164,0.0065924203497459,0.00424298158591513,-0.00172382355864776,0.0149086642581396,0.120263956187626
LYZL2,Lysozyme-like protein 2,Physical measures,X23107.Impedance of leg (right),47164,0.00984875616296658,0.00350574188164355,0.00297750207494522,0.016720010250988,0.00496873751655233
LYZL2,Lysozyme-like protein 2,Physical measures,X23108.Impedance of leg (left),47163,0.00772832755633347,0.00346883515498786,0.00092941065255727,0.0145272444601097,0.0258945819470103
LYZL2,Lysozyme-like protein 2,Physical measures,X23109.Impedance of arm (right),47158,0.000764698627274457,0.00426860493222208,-0.00760176703988081,0.00913116429442973,0.857825517386846
LYZL2,Lysozyme-like protein 2,Physical measures,X23110.Impedance of arm (left),47162,0.00254371655433963,0.00425612075273155,-0.00579828012101421,0.0108857132296935,0.550072091265836
LYZL2,Lysozyme-like protein 2,Physical measures,X23111.Leg fat percentage (right),47163,0.020594070461558,0.00724067792703247,0.00640234172457439,0.0347857991985417,0.00445592640721888
LYZL2,Lysozyme-like protein 2,Physical measures,X23112.Leg fat mass (right),47162,-7.0705407921519e-05,0.00750374897460621,-0.0147780533981497,0.0146366425823067,0.992481982879098
LYZL2,Lysozyme-like protein 2,Physical measures,X23113.Leg fat-free mass (right),47162,-0.0209267244911447,0.00555902607703185,-0.0318224156021271,-0.0100310333801623,0.000167319785144054
LYZL2,Lysozyme-like protein 2,Physical measures,X23114.Leg predicted mass (right),47161,-0.0214869446663841,0.00558451823946228,-0.0324326004157302,-0.010541288917038,0.000119602602151223
LYZL2,Lysozyme-like protein 2,Physical measures,X23115.Leg fat percentage (left),47160,0.0156857790946716,0.00747451899511527,0.00103572186424563,0.0303358363250975,0.0358658221583178
LYZL2,Lysozyme-like protein 2,Physical measures,X23116.Leg fat mass (left),47160,-0.00246173598191585,0.00779068512753788,-0.0177314788318901,0.0128080068680584,0.75201708028745
LYZL2,Lysozyme-like protein 2,Physical measures,X23117.Leg fat-free mass (left),47158,-0.0205489971176624,0.00576356818808563,-0.0318455907663102,-0.00925240346901457,0.000364132133723534
LYZL2,Lysozyme-like protein 2,Physical measures,X23118.Leg predicted mass (left),47157,-0.021085849064128,0.00578726794011828,-0.0324288942267598,-0.00974280390149616,0.000269550712211335
LYZL2,Lysozyme-like protein 2,Physical measures,X23119.Arm fat percentage (right),47157,0.00440991463032312,0.00648811111190222,-0.00830678314900524,0.0171266124096515,0.49670650837748
LYZL2,Lysozyme-like protein 2,Physical measures,X23120.Arm fat mass (right),47156,-0.000327459452254042,0.00633702809411017,-0.01274803451671,0.0120931156122019,0.958788914878394
LYZL2,Lysozyme-like protein 2,Physical measures,X23121.Arm fat-free mass (right),47155,-0.0138306286046002,0.00518122457180987,-0.0239858287653475,-0.00367542844385283,0.0076045353346642
LYZL2,Lysozyme-like protein 2,Physical measures,X23122.Arm predicted mass (right),47154,-0.014004824086684,0.00518154813375206,-0.0241606584288381,-0.00384898974453,0.00688025220990303
LYZL2,Lysozyme-like protein 2,Physical measures,X23123.Arm fat percentage (left),47151,0.00658976256488069,0.00661935384175708,-0.0063841709649632,0.0195636960947246,0.31948910635023
LYZL2,Lysozyme-like protein 2,Physical measures,X23124.Arm fat mass (left),47151,0.003183685904982,0.00630859165549404,-0.0091811537397863,0.0155485255497503,0.6138033208887
LYZL2,Lysozyme-like protein 2,Physical measures,X23125.Arm fat-free mass (left),47147,-0.0106519579802101,0.00525752833064223,-0.0209567135082688,-0.000347202452151297,0.042772155399432
LYZL2,Lysozyme-like protein 2,Physical measures,X23126.Arm predicted mass (left),47146,-0.0110538076168119,0.0052872883369644,-0.0214168927572622,-0.000690722476361713,0.0365713124378229
LYZL2,Lysozyme-like protein 2,Physical measures,X23127.Trunk fat percentage,47144,0.00438743344710727,0.00420199537289607,-0.00384847748376902,0.0126233443779836,0.296435645247187
LYZL2,Lysozyme-like protein 2,Physical measures,X23128.Trunk fat mass,47140,-0.000384472571660093,0.00458646562790099,-0.00937394520234603,0.00860500005902584,0.933194195684793
LYZL2,Lysozyme-like protein 2,Physical measures,X23129.Trunk fat-free mass,47135,-0.00930200859761652,0.0047068885483725,-0.0185275101524266,-7.65070428064094e-05,0.0481377741181237
LYZL2,Lysozyme-like protein 2,Physical measures,X23130.Trunk predicted mass,47133,-0.00849992391145876,0.00469856988040298,-0.0177091208770486,0.000709273054131076,0.0704569252971443
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23400.Total Cholesterol,36962,0.00868204793090003,0.00353149539580908,0.00176031695511422,0.0156037789066858,0.0139661892260181
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,36962,0.0111715837801087,0.00342557629470222,0.00445745424249237,0.0178857133177251,0.00111214477067286
LYZL2,Lysozyme-like protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",36962,0.0110038007053288,0.00343924889385997,0.00426287287336323,0.0177447285372943,0.00138004624378516
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23403.VLDL Cholesterol,36962,0.0161235931737038,0.00338146054491693,0.00949593050566656,0.0227512558417409,1.87848576833699e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,36962,0.00834938890343554,0.00342031917676194,0.00164556331698214,0.0150532144898889,0.0146551783273443
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23405.LDL Cholesterol,36962,0.0109557549282288,0.00339412036309187,0.00430327901656872,0.0176082308398888,0.00125025615269343
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23406.HDL Cholesterol,36962,-0.00642891361806696,0.00386933471675444,-0.0140128096629057,0.00115498242677174,0.09663626803257
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23407.Total Triglycerides,36962,0.0222443597145918,0.00345998694976411,0.0154627852930542,0.0290259341361295,1.32873901905332e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,36962,0.022852988084325,0.00351425090090876,0.0159650563185439,0.0297409198501062,8.16194998287236e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23409.Triglycerides in LDL,36962,0.0190545325324617,0.00331120441766486,0.0125645718738386,0.0255444931910848,8.88108134242878e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23410.Triglycerides in HDL,36962,0.0161231351908438,0.00326854030043399,0.00971679620199324,0.0225294741796945,8.20436452411799e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,36962,0.0109806736223625,0.00349455777648979,0.00413134038044247,0.0178300068642824,0.00168044897962482
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,36962,0.0195826124600017,0.0034139379646141,0.0128912940493581,0.0262739308706453,9.90359154801883e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23413.Phospholipids in LDL,36962,0.0106817012580213,0.00339562448224097,0.00402627727282896,0.0173371252432136,0.00166046304011114
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23414.Phospholipids in HDL,36962,-0.000243931030681184,0.00363107430169611,-0.00736083666200556,0.00687297460064319,0.946440427449561
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,36962,0.00808564744363726,0.00354445593793532,0.00113851380528403,0.0150327810819905,0.0225520116917583
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,36962,0.0140888536534735,0.00338275080795477,0.00745866206988216,0.0207190452370649,3.13470157184454e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,36962,0.0125269503729683,0.00338128176813631,0.00589963810742111,0.0191542626385154,0.000212433101535442
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,36962,-0.00712925999855336,0.0038606018319224,-0.0146960395891213,0.000437519592014541,0.0648174277313468
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23419.Total Free Cholesterol,36962,0.00995516193999753,0.00349570392993608,0.00310358223732281,0.0168067416426723,0.00440872653113977
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,36962,0.0185220050297414,0.00339766517516729,0.0118625812864135,0.0251814287730693,5.08819098840075e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,36962,0.00635996877080073,0.00343321100312717,-0.000369124795328518,0.01308906233693,0.0639788141563747
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,36962,-0.00364753936997289,0.0038374520284393,-0.0111689453457139,0.00387386660576814,0.341870331784214
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,36962,0.0143733992489815,0.00340517741399709,0.00769925151754718,0.0210475469804158,2.44814085517029e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,36962,0.0210102864363748,0.00344303847511756,0.0142619310251444,0.0277586418476052,1.07534188052177e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23425.Total Lipids in LDL,36962,0.0117883914713869,0.00339061410908549,0.00514278781757936,0.0184339951251945,0.00050913460212247
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23426.Total Lipids in HDL,36962,-0.0014265048582693,0.00371277700529003,-0.00870354778863776,0.00585053807209917,0.700825288712827
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,36962,0.00675143648844249,0.00350354195019088,-0.000115505733931625,0.0136183787108166,0.0539972744233478
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,36962,0.0179243062757396,0.00337273427058078,0.0113137471054012,0.0245348654460779,1.08719855067914e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,36962,0.0119876793935847,0.00339540009335686,0.00533269521060529,0.0186426635765642,0.00041609720921101
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,36962,0.00510756495973952,0.00350172989518096,-0.00175582563481516,0.0119709555542942,0.144703786954819
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,36962,0.0237349910691221,0.00368224833498112,0.0165177843325591,0.0309521978056851,1.19030744223539e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,36962,-0.00671168418448794,0.00338458028031625,-0.0133454615339078,-7.7906835068091e-05,0.0473862469743547
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,36962,-0.0150231863039135,0.00391970441454395,-0.0227058069564196,-0.00734056565140733,0.000127318958090231
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23434.Phosphoglycerides,36950,0.0106135749360637,0.00345387129670053,0.00384398719453062,0.0173831626775967,0.00212389317071093
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,36950,0.0212365434885992,0.00370352520211904,0.0139776340924459,0.0284954528847525,1.00171806053196e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23436.Total Cholines,36950,0.0099830753349399,0.00351365722721708,0.00309630716959443,0.0168698435002854,0.00450106193488843
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23437.Phosphatidylcholines,36950,0.00914314902735705,0.0035036280711244,0.00227603800795323,0.0160102600467609,0.00907451585246553
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23438.Sphingomyelins,36949,0.00657267073296287,0.00362795398853938,-0.000538119084574309,0.0136834605505,0.0700594575106723
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23439.Apolipoprotein B,36962,0.0118013129762741,0.00340786544820843,0.00512189669778554,0.0184807292547626,0.000535967548125173
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23440.Apolipoprotein A1,36962,0.00175256525110125,0.00360812477372226,-0.00531935930539438,0.00882448980759688,0.627168540173805
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,36962,0.00905942640615388,0.00339977613870766,0.00239586517428686,0.0157229876380209,0.00771485296318583
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23442.Total Fatty Acids,36950,0.0182227461002,0.00331406921653236,0.0117271704357966,0.0247183217646035,3.89990462093025e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23443.Degree of Unsaturation,36950,-0.0121691065995513,0.00365932418586614,-0.019341382003849,-0.00499683119525371,0.000885007051522905
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,36950,0.00828574246385533,0.00336930841243877,0.00168189797547535,0.0148895869522353,0.0139382438122309
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,36950,0.0149706438596111,0.00336509378889661,0.00837506003337378,0.0215662276858485,8.70619686738686e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,36950,0.0146083351290815,0.00336994399499628,0.00800324489888881,0.0212134253592742,1.4692256004053e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,36950,0.0211596809982111,0.00336614788071788,0.0145620311520041,0.0277573308444181,3.3604223878735e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,36950,0.0169887823970591,0.0033290193202463,0.0104639045293763,0.0235136602647418,3.38566963668562e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23449.Linoleic Acid,36950,0.0149488230918019,0.00338981934498549,0.00830477717563036,0.0215928690079735,1.04234929389695e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,36950,0.0013754065207101,0.00352068557658022,-0.00552513720938713,0.00827595025080732,0.69605167344289
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,36950,-0.000883496687108692,0.00340631522673432,-0.00755987453150796,0.00579288115729058,0.795353693057059
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,36950,-0.0145755482583603,0.00345795932848173,-0.0213531485421845,-0.00779794797453608,2.51373950166762e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,36950,-0.0173242770049299,0.00359222827210856,-0.0243650444182627,-0.0102835095915971,1.43214479138534e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,36950,0.0220666929431753,0.00367760308510273,0.0148585908963739,0.0292747949899766,2.02164951419136e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,36950,0.00361309840056518,0.00331511074240962,-0.00288451865455768,0.010110715455688,0.275782681147804
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,36950,-0.00526338333585829,0.00353831767221677,-0.0121984859734032,0.00167171930168657,0.136896761622985
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,36950,-0.0113395187542557,0.00355395345079608,-0.018305267517816,-0.00437376999069538,0.00142274607370932
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,36950,-0.0212025394638279,0.00367117816366984,-0.0283980486646208,-0.014007030263035,7.85128438561594e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,36948,-0.00298209171802245,0.00337695785113351,-0.00960092910624413,0.00363674567019923,0.3772144235469
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23460.Alanine,36958,0.00590555033097114,0.0032895486093923,-0.000541964943437762,0.01235306560538,0.0726374936920812
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23461.Glutamine,36922,-0.011308978591534,0.00326948797504476,-0.0177171750226218,-0.00490078216044632,0.000544025684007843
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23462.Glycine,36946,-0.000356227605236724,0.00340391045971196,-0.00702789210627217,0.00631543689579872,0.916653189561772
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23463.Histidine,36947,0.00192943148428885,0.00324315330943552,-0.00442714900220476,0.00828601197078246,0.551904199975081
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),36950,0.00601513371281881,0.00346629274043604,-0.000778800058435835,0.0128090674840735,0.0827073389384436
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23465.Isoleucine,36960,0.00139892608226359,0.00338054712718694,-0.00522694628702282,0.00802479845154999,0.67901529483473
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23466.Leucine,36961,0.00412233287866209,0.00348270010541372,-0.00270375932794881,0.010948425085273,0.236569147174351
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23467.Valine,36950,0.00723994295617391,0.00345528983724552,0.000467574875172691,0.0140123110371751,0.0361615893782125
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23468.Phenylalanine,36958,0.00167769186587811,0.00326273007450849,-0.00471725908015854,0.00807264281191476,0.607121686670393
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23469.Tyrosine,36947,-0.00240518446551107,0.00336397301941395,-0.00899857158356241,0.00418820265254027,0.474632128453112
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23470.Glucose,36941,-0.00759015668246951,0.00335322875188343,-0.014162485036161,-0.00101782832877798,0.0236189304697205
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23471.Lactate,36940,0.0239744989466902,0.00329117773242752,0.0175237905911323,0.0304252073022482,3.41418216527271e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23472.Pyruvate,36919,0.00778503234270574,0.00325711981927271,0.00140107749693123,0.0141689871884803,0.0168551944897519
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23473.Citrate,36961,0.00445714468365817,0.00332702245187802,-0.00206381932202274,0.0109781086893391,0.1803727135971
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,36756,0.0034564160057691,0.00325629395668531,-0.00292592014933411,0.00983875216087232,0.288502143508448
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23475.Acetate,36953,-0.011569968373438,0.00325640037966395,-0.0179525131175794,-0.00518742362929666,0.000382214031139928
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23476.Acetoacetate,36962,-0.00506932876992836,0.00323418319037197,-0.0114083278230574,0.00126967028320069,0.117040315012068
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23477.Acetone,36962,-0.0048094268145635,0.00325192113425563,-0.0111831922377045,0.00156433860857753,0.139177879274769
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23478.Creatinine,36624,0.00998052208461187,0.00404378332440039,0.00205470676878711,0.0179063374004366,0.013595680257977
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23479.Albumin,36961,0.00831968695334599,0.00333328094511577,0.00178645630091908,0.0148529176057729,0.0125743933578343
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,36962,0.0247608634159669,0.00348043282803943,0.0179392150730096,0.0315825117589241,1.18323145043475e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,36962,0.0188696853740063,0.00350133193288093,0.0120070747855597,0.0257322959624529,7.1962138897152e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,36962,0.0182060329069814,0.00352133326239966,0.0113042197126781,0.0251078461012848,2.37274705894904e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,36962,0.0191754833955046,0.00352493940909743,0.0122666021536736,0.0260843646373356,5.42535074873074e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,36962,0.0207277699588835,0.00349324101519029,0.0138810175691106,0.0275745223486565,3.03701127431985e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,36962,0.0213846335714251,0.00350256673198646,0.0145196027767317,0.0282496643661186,1.05429604780324e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,36962,0.0200437403711155,0.00346978359208392,0.013242964530631,0.0268445162116,7.79320657395133e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,36962,0.015693856648794,0.00351619986033645,0.00880210492253454,0.0225856083750534,8.13802641384172e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,36962,0.0225229339054178,0.00355202001684522,0.0155609746724012,0.0294848931384344,2.3595535520288e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,36962,0.0220087673404281,0.00355672149814868,0.0150375932040567,0.0289799414767995,6.27733476554709e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,36962,0.0210668180290991,0.0035385876274664,0.014131186279265,0.0280024497789333,2.69258957540388e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,36962,0.0205792676144911,0.00348752505479018,0.0137437185071024,0.0274148167218799,3.70628668975476e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,36962,0.0193763992930705,0.00345710933317718,0.0126004650000433,0.0261523335860978,2.12706115263686e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,36962,0.0210142095861075,0.00351046545929643,0.0141336972858865,0.0278947218863285,2.204692905619e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,36962,0.0220794088544181,0.00358923381017795,0.0150445105864693,0.0291143071223669,7.89552041381237e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,36962,0.0228816805277845,0.00351560886916699,0.0159910871442172,0.0297722739113519,7.86181885227924e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,36962,0.022451981650846,0.00351725210494145,0.0155581675251608,0.0293457957765313,1.79052077856927e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,36962,0.0223806782115947,0.00353844331803706,0.0154453293082421,0.0293160271149474,2.61451529609025e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,36962,0.021050508822653,0.00346099810957793,0.0142669525278802,0.0278340651174257,1.21838860124469e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,36962,0.0190935452626481,0.00340627525591324,0.0124172457610582,0.0257698447642381,2.1196622733627e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,36962,0.0227159879383829,0.00352211687151072,0.0158126388702219,0.0296193370065439,1.16139864819813e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,36962,0.0223862539748507,0.00353430536944653,0.0154590154507355,0.0293134924989659,2.46709966032951e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,36962,0.0171673078365512,0.00337572175527095,0.0105508931962202,0.0237837224768823,3.71679689650569e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,36962,0.0190938474756832,0.00338543948710428,0.0124583860809588,0.0257293088704076,1.73576799113389e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,36962,0.0163333961101019,0.00337734452400656,0.00971380084304899,0.0229529913771547,1.33872550219691e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,36962,0.00943684507691844,0.00341161651558896,0.00275007670636408,0.0161236134474728,0.00568119965349453
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,36962,0.00526712402482523,0.00344822636256166,-0.00149139964579562,0.0120256476954461,0.126663874620604
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,36962,0.0141596470369767,0.00337636525234672,0.00754197114237708,0.0207773229315762,2.76179244096471e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,36962,0.0234499376313148,0.0034615278186764,0.016665343106709,0.0302345321559205,1.30216985779846e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,36962,0.0202867645467729,0.00338336765628652,0.0136553639404514,0.0269181651530945,2.07523798390942e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,36962,0.0201618056239069,0.00337617815554045,0.0135444964390476,0.0267791148087662,2.40750752224953e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,36962,0.0170942609923222,0.00335821964704358,0.0105121504841168,0.0236763715005276,3.625012460573e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,36962,0.0155365526574121,0.00336464132304839,0.00894185566423726,0.0221312496505869,3.91903808473627e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,36962,0.0161613032180957,0.00336898073524455,0.00955810097701638,0.022764505459175,1.6276089152391e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,36962,0.0140492044440834,0.00336908810596085,0.00744579175640009,0.0206526171317666,3.06517164851975e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,36962,0.021927666775012,0.00341282467279133,0.015238530416341,0.028616803133683,1.36360545415974e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,36962,0.0105504673969004,0.00338967647199926,0.00390670151178186,0.017194233282019,0.00185890723537662
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,36962,0.010534565184944,0.00337710140499665,0.00391544643115055,0.0171536839387374,0.0018160648118251
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,36962,0.010596698658307,0.00335463548044102,0.00402161311664261,0.0171717841999714,0.00158767707744062
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,36962,0.00535332860746908,0.00350244515712482,-0.00151146390049557,0.0122181211154337,0.126423833896906
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,36962,0.00365369125973222,0.00354857430352252,-0.00330151437517191,0.0106088968946364,0.303206346225342
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,36962,0.00888215630200978,0.00340107090666992,0.00221605732493673,0.0155482552790828,0.00902286087397339
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,36962,0.0175725203511415,0.00332025119491742,0.0110648280091034,0.0240802126931797,1.22583474585255e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,36962,0.00546900713766508,0.00348622157662505,-0.00136398715252002,0.0123020014278502,0.116730549815769
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23524.Total Lipids in IDL,36962,0.00510500976852569,0.0035677823036427,-0.001887843546614,0.0120978630836654,0.152493165450234
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23525.Phospholipids in IDL,36962,0.00521522266746313,0.00356512301478298,-0.00177241844151151,0.0122028637764378,0.143533761123428
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23526.Cholesterol in IDL,36962,0.00308963067119414,0.00358848139973969,-0.00394379287229565,0.0101230542146839,0.389261751091957
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,36962,0.00323621435915295,0.00358520199482589,-0.00379078155070579,0.0102632102690117,0.366723569291665
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,36962,0.00255427301403244,0.00358171776678535,-0.00446589380886685,0.00957443983693173,0.475770655147616
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23529.Triglycerides in IDL,36962,0.015723407291211,0.00327948454940042,0.00929561757438613,0.0221511970080358,1.64894231824719e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,36962,0.0107559648043471,0.00340273063711108,0.00408661275560935,0.0174253168530848,0.0015759720157503
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,36962,0.0101027761635374,0.00341857019209129,0.00340237858703844,0.0168031737400363,0.00312958057442841
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,36962,0.00882166106946042,0.00342631718531705,0.002106079386239,0.0155372427526819,0.0100442383156254
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,36962,0.00929715400324717,0.00342409388242138,0.00258592999370127,0.0160083780127931,0.00663193671511399
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,36962,0.0106004284066603,0.00340480007209563,0.00392702026535286,0.0172738365479677,0.00185357575096013
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,36962,0.00544534898234145,0.00347980590029408,-0.00137507058223493,0.0122657685469178,0.117643939465518
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,36962,0.0175111655345081,0.00329323583772226,0.0110564232925725,0.0239659077764438,1.07040919596691e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,36962,0.0130789171774944,0.0033749526386159,0.00646401000580719,0.0196938243491815,0.0001070170985874
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,36962,0.0146342534215092,0.00336097388212284,0.00804674461254842,0.0212217622304699,1.34585531959065e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,36962,0.0140185897086302,0.00335522114913854,0.00744235625631864,0.0205948231609417,2.95805880725819e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,36962,0.0138176460510477,0.00336147730400886,0.00722915053519031,0.0204061415669051,3.97058652787754e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,36962,0.0155005758980381,0.00336572065840353,0.00890376340756718,0.022097388388509,4.1549810300754e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,36962,0.00854692990664157,0.00336191705084844,0.00195757248697864,0.0151362873263045,0.0110246445251298
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,36962,0.0208791944094471,0.00333705663130872,0.014338563412082,0.0274198254068122,4.05270284587364e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,36962,0.0134872053856763,0.00339223271123082,0.00683842927166386,0.0201359814996887,7.04876395722894e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,36962,0.0131895197553788,0.00338744726985809,0.00655012310645697,0.0198289164043007,9.9238645882142e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,36962,0.00988097818775516,0.00339506473716247,0.00322665130291672,0.0165353050725936,0.00361580407695716
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,36962,0.0126884486430191,0.00338082815229943,0.00606202546451223,0.019314871821526,0.000175443715614055
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,36962,0.015034068799424,0.00338314635049693,0.00840310195244998,0.0216650356463979,8.91038171120568e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,36962,0.00580572890027433,0.00336683728364511,-0.000793272175670085,0.0124047299762187,0.0846616718949487
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,36962,0.0221295520466466,0.00337772057257005,0.0155092197244093,0.0287498843688839,5.90425540201163e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,36962,-0.0117557929155571,0.00395389628359127,-0.019505429631396,-0.00400615619971818,0.00295231989685339
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,36962,-0.0151115169469433,0.00395922880758544,-0.0228716054098107,-0.00735142848407582,0.000135825012725883
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,36962,-0.0154314617121342,0.00391186157879387,-0.0230987104065702,-0.0077642130176982,8.02871044035592e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,36962,-0.0166221873415064,0.00402320377762968,-0.0245076667456606,-0.00873670793735226,3.62516826394253e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,36962,-0.0162530157492646,0.00407355992594447,-0.0242371932041158,-0.00826883829441343,6.64663814626975e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,36962,-0.0166524311080056,0.003778960549477,-0.0240591937849805,-0.00924566843103069,1.05832032708564e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,36962,0.0122762493026104,0.00321389484499819,0.00597701540641393,0.0185754831988068,0.000134207686124886
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,36962,-0.0124807506744926,0.00405014606164449,-0.0204190369553158,-0.0045424643936694,0.00206349074282333
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,36962,-0.0125698471383847,0.00398885560581091,-0.0203880041257741,-0.00475169015099533,0.00162944122636211
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,36962,-0.011478844636302,0.00390245686638767,-0.0191276600944219,-0.00383002917818219,0.00327261278672541
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,36962,-0.0152524952600257,0.00408384052641786,-0.0232568226918047,-0.00724816782824668,0.00018863003658522
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,36962,-0.015684844354993,0.00409202824132558,-0.0237052197079912,-0.0076644690019949,0.000127169082738468
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,36962,-0.0136155366191594,0.0040279814963791,-0.0215103803520624,-0.00572069288625632,0.000726344437432333
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,36962,0.00809759026487925,0.00323712852351865,0.0017528183587827,0.0144423621709758,0.0123798812755364
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,36962,0.00118821368933094,0.00356546371786841,-0.00580009519769114,0.00817652257635303,0.738946062103147
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,36962,0.00247903977569843,0.00350812953702191,-0.00439689411686451,0.00935497366826137,0.479793024717439
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,36962,0.00374268775534955,0.00344936203523857,-0.00301806183371804,0.0105034373444171,0.277924934283814
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,36962,-0.00159735689979584,0.00362043249592843,-0.00869340459181557,0.00549869079222389,0.659071078303499
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,36962,-0.00203203197568647,0.00361266806006362,-0.00911286137341116,0.00504879742203822,0.573802713610103
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,36962,0.0001806478159923,0.00363151086209392,-0.00693711347371178,0.00729840910569638,0.960326725532971
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,36962,0.0155691040288374,0.00328043237941145,0.00913945656519091,0.0219987514924838,2.09617570050361e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,36962,0.0132906348997644,0.00325139722456656,0.00691789633961391,0.0196633734599148,4.38328776041868e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,36962,0.0148965827564223,0.00326962851792317,0.00848811086129286,0.0213050546515517,5.25959170290866e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,36962,0.0141113625350484,0.00327560354414862,0.00769117958851712,0.0205315454815797,1.65923520707276e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,36962,0.0114499435303478,0.00324746288240571,0.0050849162808326,0.017814970779863,0.000423628579429023
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,36962,0.0101418177822358,0.00323259730139415,0.00380592707150326,0.0164777084929683,0.00170855027256354
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,36962,0.0138329663175534,0.00330625344626272,0.00735270956287848,0.0203132230722284,2.88443658863949e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,36962,0.02230255256757,0.00352571359882878,0.0153921539138656,0.0292129512212744,2.60309746949202e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,0.0100179870830598,0.00331918409714144,0.00351238625266259,0.016523587913457,0.00254787758237363
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,0.00144058533643992,0.00331418518454067,-0.0050552176252598,0.00793638829813964,0.663807639473394
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,0.00475675324852784,0.00328985315218833,-0.00169135892976128,0.011204865426817,0.148234238463691
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,-0.00253701098404226,0.00335183124487442,-0.00910660022399613,0.0040325782559116,0.449122293035741
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,-0.00589722768797898,0.00324904140870833,-0.0122653488490473,0.000470893473089343,0.0695376161308465
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,36795,0.00303460751427561,0.00321022734921065,-0.00325743809017727,0.00932665311872848,0.344526638638353
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,36795,-0.0134532186324524,0.00359818409610547,-0.0205056594608192,-0.00640077780408572,0.00018563065245219
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,36795,-0.0139839697460874,0.0035856181029831,-0.0210117812279343,-0.00695615826424056,9.66724223765472e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,36795,-0.0084086143265636,0.00343716839683904,-0.0151454643843681,-0.00167176426875908,0.0144431703615926
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,36795,0.00924399152680332,0.00349221814964064,0.00239924395350768,0.016088739100099,0.00813015473335164
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,36958,0.0154746265076657,0.00348610239749888,0.00864186580856787,0.0223073872067635,9.11387236705906e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,36958,-0.00490808464024331,0.00334432894427612,-0.0114629693710245,0.00164680009053788,0.142241187375519
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,36958,-0.0097235802117923,0.0034900296229962,-0.0165640382728649,-0.00288312215071974,0.00534227148678039
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,36958,0.00564844138239755,0.00326345015769433,-0.000747920926683336,0.0120448036914784,0.0835076114721472
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,36958,-0.00233697988761066,0.00321296960996863,-0.00863440032314918,0.00396044054792787,0.467019536012576
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,36962,-0.00894690687512716,0.00352964995406883,-0.0158650207851021,-0.00202879296515226,0.0112631441162925
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,36962,-0.0173519883267213,0.00367317282802857,-0.0245514070696573,-0.0101525695837853,2.3367635187558e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,36962,-0.0185036755405945,0.00368490599137879,-0.0257260912836969,-0.0112812597974921,5.19495098493028e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,36962,-0.0134717139524277,0.00360429369373354,-0.0205361295921454,-0.00640729831270993,0.000186512097929598
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,36962,0.0157459029146183,0.00365150706674622,0.00858894906379571,0.0229028567654409,1.62845704323954e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,36962,-0.0116903698904559,0.00351455686008526,-0.018578901336223,-0.00480183844468874,0.000882581926231735
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,36962,-0.00879363698226747,0.0033889566995483,-0.0154359921133821,-0.00215128185115279,0.00947536899886761
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,36962,-0.00602676007844833,0.00328971533265822,-0.0124746021304584,0.000421081973561791,0.06697403621511
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,36962,-0.0120463753701286,0.00354041900885277,-0.01898559662748,-0.00510715411277716,0.000669651724922278
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,36962,0.00972767734138359,0.00342745589299307,0.00300986379111716,0.01644549089165,0.00454437930053718
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,36962,0.00367564414531571,0.00343232816931713,-0.00305171906654586,0.0104030073571773,0.284238850692283
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,36962,-0.0143015217739994,0.00360306754180282,-0.0213635341559329,-0.00723950939206587,7.24799858876434e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,36962,-0.014772537801481,0.00364429374401884,-0.0219153535397579,-0.00762972206320409,5.07251461570293e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,36962,-0.00757100619952831,0.00328083823218218,-0.0140014491346054,-0.00114056326445124,0.0210344582309845
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,36962,0.0154908888213871,0.00356455578966597,0.00850435947364183,0.0224774181691324,1.39806973089878e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,36962,-0.000461458155900037,0.0033232438644067,-0.00697501613013716,0.00605209981833709,0.88956469449647
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,36962,-0.00932987022009563,0.00346628604635192,-0.0161237908709454,-0.00253594956924586,0.00711995705308203
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,36962,-0.00760291400653136,0.00343692307490656,-0.0143392832333482,-0.000866544779714504,0.0269750022079015
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,36962,-0.00847810213982479,0.00338161452996108,-0.0151060666185485,-0.00185013766110108,0.0121840578556796
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,36962,0.0117897823503475,0.0034940005498209,0.00494154127269849,0.0186380234279964,0.000742200937257726
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,36962,-0.0102548469562838,0.0033106180465268,-0.0167436583274763,-0.00376603558509128,0.00195531605348784
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,36962,-0.00395931621685316,0.00347753425289712,-0.0107752833525315,0.00285665091882519,0.254915359164545
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,36962,0.0100651459042337,0.00326834272385548,0.00365919416547694,0.0164710976429904,0.00207716742643907
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,36962,-0.0198201310511988,0.00365686809376429,-0.0269875925149768,-0.0126526695874208,6.06627353693636e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,36962,0.00799036516889495,0.00338801986217711,0.00134984623902782,0.0146308840987621,0.0183676448528462
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,36962,-0.00856856157391972,0.00327832268139254,-0.0149940740294491,-0.00214304911839034,0.00896692819342619
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,36962,-0.00229756524108206,0.00340700972464171,-0.00897530430137982,0.0043801738192157,0.500091722458436
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,36962,0.0149022441776444,0.0033900470602206,0.00825775193961203,0.0215467364156768,1.11192769712986e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,36962,-0.0209865446881049,0.00354866496549684,-0.0279419280204787,-0.014031161355731,3.42371492898041e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,36962,0.0071787398573665,0.00330779085477585,0.000695469782005831,0.0136620099327272,0.030005661863451
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,36962,-0.0178920622564007,0.00334754787711719,-0.0244532560955504,-0.011330868417251,9.2020794876551e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,36962,0.00461608968221097,0.00329253448784973,-0.00183727791397451,0.0110694572783964,0.160942897568388
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,36962,0.017984178802715,0.00335249707075399,0.0114132845440372,0.0245550730613928,8.25937774933346e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,36962,-0.0153257843815503,0.00338075960166874,-0.021952073200821,-0.00869949556227956,5.86011627480702e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,36962,0.0145067450336338,0.0033970132345471,0.00784859909392143,0.0211648909733461,1.96461499774469e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,36958,-0.01475608627359,0.00370640942673398,-0.0220206487499886,-0.00749152379719136,6.89282556212752e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,36958,0.00231133400793187,0.00340253199064678,-0.00435762869373582,0.00898029670959957,0.496960912137622
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,36958,0.00013920445029182,0.00325332778128412,-0.00623731800102505,0.00651572690160869,0.965870922041318
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,36958,0.00782424724611094,0.00391940227857029,0.000142218780113178,0.0155062757121087,0.0459234836757442
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,36958,0.0230596252105678,0.00364071585693349,0.0159238221309781,0.0301954282901574,2.46989284283717e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,36962,0.00873903268309774,0.00367003639925395,0.00154576134056,0.0159323040256355,0.0172712804761879
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,36962,-0.0158645020627073,0.00374106316308585,-0.0231969858623556,-0.00853201826305907,2.24412600922317e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,36962,-0.0136239117708397,0.00361414604786677,-0.0207076380246586,-0.00654018551702084,0.000164222257715026
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,36962,-0.0120971947182877,0.00367567362882659,-0.0193015150307878,-0.00489287440578753,0.00100042314676996
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,36962,0.0180672722095347,0.00353938364507119,0.0111300802651952,0.0250044641538742,3.36073249755596e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,36962,0.0090321992536649,0.00369735743223193,0.00178537868649033,0.0162790198208395,0.0145837092362705
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,36962,-0.014471508909378,0.00361833695187223,-0.0215634493350475,-0.0073795684837084,6.38272010227296e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,36962,-0.0136020058389621,0.003456939628182,-0.0203776075101989,-0.00682640416772541,8.37320747883096e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,36962,-0.00725983413484241,0.00391449725070181,-0.014932248746218,0.000412580476533135,0.0636755448166161
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,36962,0.0166773064013826,0.00351354167864458,0.00979076471123923,0.023563848091526,2.0907281683757e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,36962,-0.00368555478933819,0.00326533683186934,-0.0100856149798021,0.00271450540112572,0.259049067630069
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,36962,-0.00735520965329881,0.00326427851694682,-0.0137531955465146,-0.000957223760083048,0.0242603575412108
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,36962,-0.00656243070710333,0.00320012361140585,-0.0128346729854588,-0.00029018842874786,0.0403179317418004
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,36962,-0.00207153400157151,0.00358403493470695,-0.00909624247359714,0.00495317447045411,0.563281246703491
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,36962,0.0183101067538491,0.00359280687104277,0.0112682052866053,0.025352008221093,3.51135648802309e-07
LYZL2,Lysozyme-like protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47194,-0.00374664623634,0.00281648377377244,-0.00926695443293398,0.00177366196025398,0.183446729707463
LYZL2,Lysozyme-like protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47194,-0.00315001103831144,0.00275663349709815,-0.00855301269262381,0.00225299061600094,0.253173999072726
LYZL2,Lysozyme-like protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45482,-0.00382760615423955,0.00266407362656767,-0.00904919046231218,0.00139397815383307,0.150803684971259
LYZL2,Lysozyme-like protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45482,-0.00152517402031922,0.00288660543227515,-0.0071829206675785,0.00413257262694007,0.597253192821742
LYZL2,Lysozyme-like protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45482,-0.00529957758307937,0.00286689796478243,-0.0109186975940529,0.000319542427894194,0.0645378055363866
LYZL2,Lysozyme-like protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45482,-0.00309048122418791,0.00263935218319448,-0.0082636115032491,0.00208264905487327,0.241642169095701
LYZL2,Lysozyme-like protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,47194,0.0311136756798566,0.0706480474420591,-0.107356497306579,0.169583848666292,0.659648679867594
LYZL2,Lysozyme-like protein 2,Working and living environment,X24010.Inverse distance to the nearest road,47194,-0.00123986911085131,0.0024702757230346,-0.00608160952799913,0.00360187130629651,0.615731858023265
LYZL2,Lysozyme-like protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,47194,0.00124477480735368,0.00248664643368058,-0.00362905220266025,0.00611860181736762,0.616668819495229
LYZL2,Lysozyme-like protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,47194,-3.1919853847011e-05,0.00252467436375938,-0.0049802816068154,0.00491644189912138,0.989912597226555
LYZL2,Lysozyme-like protein 2,Working and living environment,X24013.Total traffic load on major roads,47194,0.0115547200052655,0.0493723098109068,-0.0852150072241118,0.108324447234643,0.814961881148796
LYZL2,Lysozyme-like protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,47194,0.00611967414625574,0.0480015093229837,-0.0879632841267922,0.100202632419304,0.898554317175913
LYZL2,Lysozyme-like protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47194,-0.00425267146303155,0.0028299254800269,-0.00979932540388427,0.00129398247782117,0.132916970159886
LYZL2,Lysozyme-like protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47194,-0.00484232542234046,0.00282902967783898,-0.0103872235909049,0.000702572746223928,0.0869733834511303
LYZL2,Lysozyme-like protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47194,-0.00385517108632667,0.00280115430867748,-0.00934543353133454,0.00163509135868119,0.16874834241137
LYZL2,Lysozyme-like protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47150,0.000259852124834413,0.00271001690919595,-0.00505178101718964,0.00557148526685847,0.923612101799256
LYZL2,Lysozyme-like protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,47194,5.88715735728352e-05,0.00247040305164248,-0.00478311840764642,0.00490086155479209,0.980987810649032
LYZL2,Lysozyme-like protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,47194,8.28492925168995e-05,0.00247013062914802,-0.00475860674061322,0.00492430532564702,0.97324389652112
LYZL2,Lysozyme-like protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,47194,5.15345008465632e-05,0.0024704317083277,-0.00479051164747572,0.00489358064916885,0.983357095122589
LYZL2,Lysozyme-like protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47194,5.54022814789129e-05,0.00247030077603766,-0.0047863872395549,0.00489719180251273,0.982107261474395
LYZL2,Lysozyme-like protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47194,6.55000322068307e-05,0.00247042244258989,-0.00477652795526935,0.00490752801968301,0.978847835512253
LYZL2,Lysozyme-like protein 2,Health and medical history,X2405.Number of children fathered,34284,0.295152676525252,0.0552197039702141,0.186922056743632,0.403383296306872,9.22947131961313e-08
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44406,0.00528163799195927,0.00291891036794624,-0.000439426329215356,0.0110027023131339,0.0703948979981526
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44406,-0.00425772436083467,0.0026589624033802,-0.00946929067145987,0.000953841949790522,0.109331868824199
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",44406,0.00296917488721289,0.00259615909489689,-0.00211929693878501,0.0080576467132108,0.252769750774164
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44406,0.00369850452088243,0.00275833289342396,-0.00170782795022852,0.00910483699199338,0.179984704998325
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44406,-0.00400429617575811,0.00270033187291404,-0.00929694664666964,0.00128835429515341,0.138118873899038
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",44406,0.00182226884678712,0.00260955919782498,-0.00329246718094983,0.00693700487452408,0.484994229743217
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47278,0.00296648992907007,0.00277516575269604,-0.00247283494621417,0.00840581480435432,0.28510703447458
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47278,0.000702996671692104,0.00261704286297791,-0.00442640733974459,0.0058324006831288,0.788222540121409
LYZL2,Lysozyme-like protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,47278,0.000596335007566889,0.00250126129222802,-0.00430613712520002,0.0054988071403338,0.811562313786993
LYZL2,Lysozyme-like protein 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,27927,-0.202310350779142,0.0849271397583092,-0.368767544705428,-0.0358531568528561,0.0172569481420345
LYZL2,Lysozyme-like protein 2,Health and medical history,X2704.Years since last cervical smear test,33715,0.0283783714528524,0.0507362695032803,-0.0710647167735769,0.127821459679282,0.575948511384582
LYZL2,Lysozyme-like protein 2,Health and medical history,X2714.Age when periods started (menarche),36538,0.0681579895748978,0.0445926167723348,-0.0192435392988785,0.155559518448674,0.126423545973689
LYZL2,Lysozyme-like protein 2,Health and medical history,X2734.Number of live births,36940,-0.0805242452957896,0.0418929560260764,-0.162634439106899,0.00158594851532022,0.0546094955195489
LYZL2,Lysozyme-like protein 2,Health and medical history,X2744.Birth weight of first child,33696,-0.055759608034251,0.0484379301692537,-0.150697951165988,0.0391787350974864,0.249696118211733
LYZL2,Lysozyme-like protein 2,Health and medical history,X2754.Age at first live birth,32000,-0.00179273729881348,0.00419469537262983,-0.0100143402291679,0.00642886563154098,0.669112418890529
LYZL2,Lysozyme-like protein 2,Health and medical history,X2764.Age at last live birth,31977,-0.00571447908117948,0.00418824588515815,-0.0139234410160895,0.0024944828537305,0.172476795091239
LYZL2,Lysozyme-like protein 2,Health and medical history,X2794.Age started oral contraceptive pill,34994,-0.00490662535459231,0.0041474612522147,-0.0130356494089331,0.0032223986997485,0.236817330511182
LYZL2,Lysozyme-like protein 2,Health and medical history,X2804.Age when last used oral contraceptive pill,33978,-0.0012067834211054,0.00370726457049918,-0.0084730219792838,0.006059455137073,0.744795369140932
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,28481,0.00482891720464583,0.00527152268847309,-0.00550326726476142,0.0151611016740531,0.359694555694112
LYZL2,Lysozyme-like protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34078,0.0303552204512332,0.0595746240921669,-0.0864110427694138,0.14712148367188,0.610389873267546
LYZL2,Lysozyme-like protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34073,0.00800970434520349,0.0661444037606587,-0.121633327025687,0.137652735716094,0.90361879756047
LYZL2,Lysozyme-like protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34089,0.0412733854986862,0.0670928567596434,-0.0902286137502149,0.172775384747587,0.538457397137708
LYZL2,Lysozyme-like protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34062,0.0431649468304263,0.0656729011187222,-0.0855539393622692,0.171883833023122,0.511020987184547
LYZL2,Lysozyme-like protein 2,Mental health,X28739.Difficulty with standing for long periods,34106,0.00200754784616755,0.0625631439204501,-0.120616214237915,0.12463130993025,0.974402221895334
LYZL2,Lysozyme-like protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,34123,-0.032285558806052,0.0702769745815652,-0.17002842898592,0.105457311373816,0.645953446086692
LYZL2,Lysozyme-like protein 2,Mental health,X28741.Difficulty learning a new task,34046,-0.0215328897049034,0.0780169926913019,-0.174446195379855,0.131380415970048,0.782551700848175
LYZL2,Lysozyme-like protein 2,Mental health,X28742.Difficulty with joining in community activities,33670,0.0462202525583947,0.0744695476376369,-0.0997400608113736,0.192180565928163,0.534837925299756
LYZL2,Lysozyme-like protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,34051,-0.0249203302377061,0.0648290036593065,-0.151985177409947,0.102144516934535,0.700689323568916
LYZL2,Lysozyme-like protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34121,0.0937153967213896,0.0857239213980239,-0.0743034892187373,0.261734282661516,0.274321397641039
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28355,-0.00118486958271928,0.0809348021164506,-0.159817081730962,0.157447342565524,0.988320194067766
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2897.Age stopped smoking,28483,-0.00804519471156563,0.00639305383934722,-0.0205755802366862,0.00448519081355491,0.208300743357422
LYZL2,Lysozyme-like protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32954,-0.00497926094042751,0.00786678885823578,-0.0203981671025696,0.0104396452217146,0.526784124947676
LYZL2,Lysozyme-like protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32954,0.00206874988183302,0.00844149514104124,-0.0144765805946078,0.0186140803582738,0.806408433432221
LYZL2,Lysozyme-like protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32954,0.0484083717215695,0.0281435708383829,-0.00675302712166107,0.1035697705648,0.085457228538658
LYZL2,Lysozyme-like protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32954,0.012866224302795,0.028190329053871,-0.0423868206427921,0.0681192692483821,0.64810923265667
LYZL2,Lysozyme-like protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32954,-0.00752662142800486,0.030031942337385,-0.0663892284092795,0.0513359855532697,0.802113166169328
LYZL2,Lysozyme-like protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32954,-0.00921097421534017,0.025492569147143,-0.0591764097437404,0.0407544613130601,0.71786866350528
LYZL2,Lysozyme-like protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32954,0.00146859618938866,0.0117253534413298,-0.0215130965556177,0.024450288934395,0.900328695406925
LYZL2,Lysozyme-like protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32954,0.0363985139116581,0.0211247168484831,-0.0050059311113687,0.0778029589346849,0.0849171539538402
LYZL2,Lysozyme-like protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32899,-0.00738412082666579,0.06916556301985,-0.142948624345572,0.12818038269224,0.914981690187181
LYZL2,Lysozyme-like protein 2,Mental health,X29003.Recent feelings of depression,32898,-0.0199231012323631,0.0670698362743604,-0.15137998033011,0.111533777865383,0.766435091946612
LYZL2,Lysozyme-like protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32904,0.00229760417814227,0.0550260176256366,-0.105553390368105,0.11014859872439,0.966695034556321
LYZL2,Lysozyme-like protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,32910,0.00118829562305348,0.0561168288058181,-0.10880068883635,0.111177280082457,0.983106214342428
LYZL2,Lysozyme-like protein 2,Mental health,X29006.Recent poor appetite or overeating,32915,0.0215816124096929,0.0729473951926499,-0.121395282167901,0.164558506987287,0.767350108009725
LYZL2,Lysozyme-like protein 2,Mental health,X29007.Recent feelings of inadequacy,32883,-0.052959157560379,0.0723515243052047,-0.19476814519858,0.0888498300778222,0.464205789890461
LYZL2,Lysozyme-like protein 2,Mental health,X29008.Recent trouble concentrating on things,32914,-0.0757023140528237,0.0727034851411257,-0.21820114492943,0.0667965168237828,0.2977885562481
LYZL2,Lysozyme-like protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32903,-0.148674090590327,0.132105710846239,-0.407601283848957,0.110253102668302,0.260441995701972
LYZL2,Lysozyme-like protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,32851,-0.23300883337466,0.145762924798753,-0.518704165980216,0.0526864992308951,0.10995652124827
LYZL2,Lysozyme-like protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,31326,0.0297628345841108,0.0156998670108121,-0.00100890475708096,0.0605345739253025,0.0580332777794059
LYZL2,Lysozyme-like protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31326,-0.0159768245676831,0.0275414965478957,-0.0699581578015586,0.0380045086661924,0.561864630467753
LYZL2,Lysozyme-like protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31326,-0.00131598562059436,0.0155810305479586,-0.0318548054945932,0.0292228342534045,0.932692367951472
LYZL2,Lysozyme-like protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31326,0.00120595682339318,0.045721087241613,-0.0884073741701683,0.0908192878169547,0.978957837649656
LYZL2,Lysozyme-like protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31326,-0.00233010498388572,0.0267595382985457,-0.0547788000490352,0.0501185900812638,0.930613691944346
LYZL2,Lysozyme-like protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31326,0.000647426880789937,0.0291228289824182,-0.0564333179247498,0.0577281716863297,0.982264358143479
LYZL2,Lysozyme-like protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31326,0.0146191910579134,0.0337312658498973,-0.0514940900078852,0.0807324721237121,0.664735420178199
LYZL2,Lysozyme-like protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31326,0.0252553359748623,0.0391799411689638,-0.0515373487163066,0.102048020666031,0.51920713416179
LYZL2,Lysozyme-like protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31326,-0.0471514878216551,0.0313525346232815,-0.108602455683287,0.0142994800399766,0.132646039296814
LYZL2,Lysozyme-like protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31326,0.012525586175146,0.0158879177051697,-0.0186147325269866,0.0436659048772785,0.430504295338768
LYZL2,Lysozyme-like protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31326,0.0234898789984532,0.0233743356691389,-0.022323818913059,0.0693035769099655,0.314956783626892
LYZL2,Lysozyme-like protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31326,-0.0155880775684323,0.0365152782059884,-0.0871580228521696,0.055981867715305,0.669470353389469
LYZL2,Lysozyme-like protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31326,0.0760083654742128,0.0444722544927139,-0.0111572533315063,0.163173984279932,0.0874705078142517
LYZL2,Lysozyme-like protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31326,0.028585335928516,0.0289678962278486,-0.0281917406780672,0.0853624125350993,0.323775788258711
LYZL2,Lysozyme-like protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31326,0.0255036418484845,0.0460394176386403,-0.0647336167232504,0.115740900420219,0.579628072733793
LYZL2,Lysozyme-like protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31326,-0.0199179806004909,0.0442049418723916,-0.106559666670378,0.0667237054693965,0.652303445567186
LYZL2,Lysozyme-like protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31326,0.0107970654808889,0.0240670659991953,-0.0363743838775339,0.0579685148393118,0.653715875511479
LYZL2,Lysozyme-like protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31326,-0.00549355583024837,0.0237674585541541,-0.0520777745963905,0.0410906629358937,0.817214157231825
LYZL2,Lysozyme-like protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31326,0.0284862957610263,0.0336764679510331,-0.0375195814229985,0.0944921729450511,0.397646053232132
LYZL2,Lysozyme-like protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,32767,0.0264325300493939,0.0639268216401891,-0.0988640403653767,0.151729100464164,0.679264151973008
LYZL2,Lysozyme-like protein 2,Mental health,X29059.Recent inability to stop or control worrying,32769,0.0508499705717455,0.067014048982003,-0.0804975654329804,0.182197506576471,0.447994871337979
LYZL2,Lysozyme-like protein 2,Mental health,X29060.Recent worrying too much about different things,32764,0.00218042238461097,0.0619372260920174,-0.119216540755743,0.123577385524965,0.971918064391706
LYZL2,Lysozyme-like protein 2,Mental health,X29061.Recent trouble relaxing,32769,-0.0101351307995551,0.0648561539027295,-0.137253192448905,0.116982930849795,0.8758230192227
LYZL2,Lysozyme-like protein 2,Mental health,X29062.Recent restlessness,32771,0.0258547795458618,0.0899449153087949,-0.150437254459376,0.2021468135511,0.773773499691013
LYZL2,Lysozyme-like protein 2,Mental health,X29063.Recent easy annoyance or irritability,32758,-0.00960847476461515,0.065485969699632,-0.137960975375894,0.118744025846664,0.883351856996973
LYZL2,Lysozyme-like protein 2,Mental health,X29064.Recent feelings of foreboding,32752,-0.0194962563086555,0.0745898555897311,-0.165692373264529,0.126699860647218,0.793805948722169
LYZL2,Lysozyme-like protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31326,0.00277197115599133,0.0160992368669501,-0.0287825331032309,0.0343264754152135,0.863300465250325
LYZL2,Lysozyme-like protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31326,0.0140778887384846,0.0257681598025174,-0.0364277044744495,0.0645834819514187,0.584856243482802
LYZL2,Lysozyme-like protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31326,-0.0305599677366061,0.0346331239120467,-0.0984408906042177,0.0373209551310054,0.377593639412606
LYZL2,Lysozyme-like protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31326,0.0440449958923947,0.0386360177199287,-0.0316815988386656,0.119771590623455,0.254323564876997
LYZL2,Lysozyme-like protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31326,0.00416153212929032,0.0243330578067291,-0.0435312611718987,0.0518543254304794,0.86420968238003
LYZL2,Lysozyme-like protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31326,-0.0115494263148741,0.0260421244490931,-0.0625919902350967,0.0394931376053484,0.657424075610478
LYZL2,Lysozyme-like protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31326,0.0392918308312831,0.0259956043638782,-0.0116595537219182,0.0902432153844844,0.130708574612181
LYZL2,Lysozyme-like protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31326,-0.00228701309900232,0.0241322409289297,-0.0495862053197044,0.0450121791216998,0.924500038763387
LYZL2,Lysozyme-like protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31326,0.0277332019664005,0.0317433902124982,-0.034483842850096,0.089950246782897,0.382326878126528
LYZL2,Lysozyme-like protein 2,Mental health,X29076.Felt loved as a child,32731,0.0790743927318227,0.0579248535261815,-0.0344583201794931,0.192607105643138,0.172249876480769
LYZL2,Lysozyme-like protein 2,Mental health,X29077.Physically abused by family as a child,32734,-0.164033746710444,0.076098060439229,-0.313185945171332,-0.0148815482495548,0.0311450441710744
LYZL2,Lysozyme-like protein 2,Mental health,X29078.Felt hated by family member as a child,32721,-0.0337238023520828,0.0760816598338288,-0.182843855626387,0.115396250922222,0.657589975478701
LYZL2,Lysozyme-like protein 2,Mental health,X29079.Sexually molested as a child,32662,0.0624125355122477,0.102255261179683,-0.138007776399931,0.262832847424426,0.541639030099932
LYZL2,Lysozyme-like protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,32722,0.159911205334026,0.0889648162804723,-0.0144598345756995,0.334282245243752,0.0722957613809507
LYZL2,Lysozyme-like protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32718,-0.147356481385676,0.106554251221078,-0.356202813778989,0.0614898510076374,0.166722888436099
LYZL2,Lysozyme-like protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32673,-0.0602237740301734,0.0825808307083387,-0.222082202218517,0.10163465415817,0.465855519728353
LYZL2,Lysozyme-like protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32725,-0.131169025958822,0.0920947584056303,-0.311674752433857,0.0493367005162135,0.154399683708658
LYZL2,Lysozyme-like protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32694,-0.0543172187408531,0.12978920481731,-0.30870406018278,0.200069622701074,0.675589302732498
LYZL2,Lysozyme-like protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32693,0.0202753548357026,0.12441388519169,-0.22357586014001,0.264126569811415,0.870548163604564
LYZL2,Lysozyme-like protein 2,Mental health,X29086.Experienced a violent or sexual assault,32727,0.0238146015013072,0.0985825037585422,-0.169407105865436,0.21703630886805,0.809118751913149
LYZL2,Lysozyme-like protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,32734,0.0316326971696519,0.0694454103691344,-0.104480307153851,0.167745701493155,0.648757474466862
LYZL2,Lysozyme-like protein 2,Mental health,X29088.Experienced a marital separation or divorce,32735,0.105815893838088,0.0619870538285307,-0.0156787316658325,0.227310519342008,0.0878450630434416
LYZL2,Lysozyme-like protein 2,Mental health,X29089.Experienced the death of a spouse or partner,32744,-0.221549302341371,0.104704005239957,-0.426769152611686,-0.0163294520710555,0.0343761057598981
LYZL2,Lysozyme-like protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32733,-0.133172520831415,0.0792195948403244,-0.288442926718451,0.0220978850556205,0.092787370086591
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,32739,-0.0648437542125924,0.0525860214101765,-0.167912356176538,0.0382248477513535,0.217571601265567
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31825,-0.0864811722462021,0.0589618607170389,-0.202046419251598,0.029084074759194,0.142488817966015
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31835,-0.0861894168802348,0.0583829393830428,-0.200619978070999,0.0282411443105291,0.139908922174009
LYZL2,Lysozyme-like protein 2,Mental health,X29104.Ever used cannabis,32728,0.0162625117324369,0.0678490888908162,-0.116721702493563,0.149246725958437,0.810578830376238
LYZL2,Lysozyme-like protein 2,Mental health,X29108.Ever thought that life not worth living,32690,-0.0967385289669755,0.064252245898225,-0.222672930927497,0.0291958729935455,0.132204272422555
LYZL2,Lysozyme-like protein 2,Mental health,X29109.Ever contemplated self-harm,32701,-0.0721542032320366,0.0835537899373837,-0.235919631509309,0.0916112250452354,0.387849836306357
LYZL2,Lysozyme-like protein 2,Mental health,X29111.Ever self-harmed,32721,-0.113443716844666,0.132468729669537,-0.373082426996959,0.146194993307627,0.391810174002872
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32728,0.0791008902977581,0.0875506877507283,-0.0924984576936693,0.250700238289186,0.366292137242284
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,31860,0.0486770120915166,0.032252812090504,-0.0145384996058712,0.111892523788904,0.131278711465915
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,31860,0.0162031940985844,0.0259304321048798,-0.0346204528269801,0.0670268410241489,0.532073066059544
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,31860,0.03886338645991,0.0266391253886753,-0.0133492993018935,0.0910760722217136,0.144636373411419
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,31860,0.0244737712177995,0.0356644537343102,-0.0454285581014484,0.0943761005370475,0.492592334195728
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32718,-0.0958826417250469,0.058814193216212,-0.211158460428822,0.0193931769787287,0.103081342995502
LYZL2,Lysozyme-like protein 2,Health and medical history,X29153.Pain or discomfort today,32730,0.106457381670225,0.0564136705268616,-0.00411341256242348,0.217028175902874,0.0591815529960447
LYZL2,Lysozyme-like protein 2,Mental health,X29154.Anxiety or depression today,32730,0.028474772584942,0.0681052675918385,-0.105011551895061,0.161961097064945,0.675884556907345
LYZL2,Lysozyme-like protein 2,Mental health,X29166.Frequency of confiding in someone close,32533,0.0337620951111293,0.0542393323872761,-0.072546996367932,0.14007118659019,0.533652413156283
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32701,0.0145218240660877,0.00818326719283694,-0.00151737963187273,0.0305610277640481,0.0760024379540809
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32701,-0.00441040736720444,0.00815233767377897,-0.0203889892078112,0.0115681744734024,0.588521831367944
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32701,-0.0146195846231365,0.0102038755507948,-0.0346191807026943,0.00538001145642128,0.151965158476535
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32701,-0.0170644955578698,0.0120090609393425,-0.0406022549989811,0.00647326388324159,0.155361227780457
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32701,-0.0117361743000711,0.0186114571228722,-0.0482146302609006,0.0247422816607584,0.528325797326328
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32701,-0.0168872369081214,0.00876907780386262,-0.0340746294036921,0.000300155587449384,0.0541649888855526
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32698,-0.00656732514172191,0.00957585841286774,-0.0253360076309427,0.0122013573474989,0.492843958340408
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32698,0.00184905095197962,0.0135854215952965,-0.0247783753748014,0.0284764772787607,0.891740958955319
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32698,0.00657417802487795,0.0220631401888344,-0.0366695767452375,0.0498179327949934,0.765732229671271
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32698,-0.00125666637481511,0.0214424205681297,-0.0432838106883493,0.0407704779387191,0.953266815453728
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32698,0.0106842396341476,0.0292120959973441,-0.0465714685206469,0.0679399477889421,0.714562544152948
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32698,-0.00142159895454854,0.0142178099320899,-0.0292885064214448,0.0264453085123477,0.92035675811471
LYZL2,Lysozyme-like protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,32541,-0.0451513940180852,0.0661095932605623,-0.174726196808787,0.0844234087726169,0.494639008222889
LYZL2,Lysozyme-like protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,32658,-0.0531340682117399,0.0615943455325744,-0.173858985455586,0.067590849032106,0.3883560714466
LYZL2,Lysozyme-like protein 2,Mental health,X29173.Frequency of feeling left out,32613,0.00318150892180715,0.0625553586587582,-0.119426994049359,0.125790011892973,0.959438961485156
LYZL2,Lysozyme-like protein 2,Mental health,X29174.Frequency of feeling isolated from others,32641,-0.0275575043584123,0.0645662083984525,-0.154107272819379,0.0989922641025545,0.669528176411613
LYZL2,Lysozyme-like protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,32715,-0.120691605934868,0.0543641369132156,-0.22724531428477,-0.0141378975849652,0.0264399778279724
LYZL2,Lysozyme-like protein 2,Mental health,X29176.Ability to make it through stressful events,32715,-0.0383748448269848,0.0536320884661101,-0.143493738220561,0.0667440485665911,0.474306510773799
LYZL2,Lysozyme-like protein 2,Mental health,X29177.Quick recovery from stressful events,32715,0.0323862279758166,0.0545600433130911,-0.0745514569178419,0.139323912869475,0.552802373269328
LYZL2,Lysozyme-like protein 2,Mental health,X29178.Hard to snap back when something bad happens,32715,-0.0710018763383613,0.0533796339848106,-0.17562595894859,0.0336222062718673,0.183509564364911
LYZL2,Lysozyme-like protein 2,Mental health,X29179.Comes through difficult times with little trouble,32715,-0.000393787871432258,0.0543082748459235,-0.106838006569442,0.106050430826578,0.994214774142789
LYZL2,Lysozyme-like protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,32715,0.00286042992717134,0.053834774390072,-0.10265572787737,0.108376587731713,0.957626739839309
LYZL2,Lysozyme-like protein 2,Mental health,X29181.General happiness,32659,0.0904915001339518,0.056054665140829,-0.019375643542073,0.200358643809977,0.1064887511093
LYZL2,Lysozyme-like protein 2,Mental health,X29182.Belief that own life is meaningful,32578,-0.0059887531930612,0.0557273343452865,-0.115214328509823,0.1032368221237,0.91442234769409
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28082,-0.112981055589615,0.0764362329563478,-0.262796072184057,0.0368339610048267,0.139453316369414
LYZL2,Lysozyme-like protein 2,Health and medical history,X2946.Father's age,32382,0.000143444157722043,0.00610507540687243,-0.0118225036397479,0.012109391955192,0.981255269926021
LYZL2,Lysozyme-like protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,28246,0.0107627280106226,0.00987912944721689,-0.00860036570592247,0.0301258217271677,0.276019341655521
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,46780,0.0138017926092374,0.0025837232812753,0.00873769497793782,0.018865890240537,9.28936262590018e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,46780,0.014990889593787,0.00305433169495232,0.0090043994716805,0.0209773797158936,9.26060608729946e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30020.Haemoglobin concentration,46780,0.00929264857059695,0.00325911680564986,0.00290477963152323,0.0156805175096707,0.0043582754369692
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30030.Haematocrit percentage,46780,0.00784639128931342,0.0031950243710474,0.00158414352206052,0.0141086390565663,0.0140638863605809
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30040.Mean corpuscular volume,46780,-0.0113594470588614,0.00257933199226492,-0.0164149377637006,-0.00630395635402213,1.06740811961845e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,46779,-0.00890526297816246,0.00258872589398473,-0.0139791657303725,-0.0038313602259524,0.000582711645533654
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,46779,0.00194213377964829,0.00253454344831642,-0.00302557137905189,0.00690983893834847,0.443526098340837
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,46780,-0.00460343149442528,0.0024631757645386,-0.00943125599292094,0.000224393004070368,0.0616493424116778
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30080.Platelet count,46780,0.0220160102033823,0.00260742162843448,0.0169054638116507,0.0271265565951139,3.25733624187768e-17
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30090.Platelet crit,46780,0.0322349169155006,0.00266676701396695,0.0270080535681254,0.0374617802628758,1.55291625620673e-33
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,46780,0.00950094880703078,0.002511184489413,0.0045790272077813,0.0144228704062803,0.00015506071910715
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30110.Platelet distribution width,46780,0.00444876862670478,0.00249128889363131,-0.000434157604812579,0.00933169485822214,0.074156247204695
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30120.Lymphocyte count,46748,0.0063382905885964,0.00263320402221741,0.00117721070505027,0.0114993704721425,0.0160892181353103
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30130.Monocyte count,46748,0.00397617195799405,0.0026323663263297,-0.00118326604161216,0.00913560995760026,0.130931377451343
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30140.Neutrophill count,46748,0.0141041145788956,0.00256353059501667,0.00907959461266288,0.0191286345451282,3.79890102402383e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30150.Eosinophill count,46748,0.00651778059920396,0.00250587640057768,0.00160626285407171,0.0114292983443362,0.00930126609935056
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30160.Basophill count,46748,-0.0332315781598693,0.0356672661175605,-0.103139419750288,0.0366762634305492,0.351495815353581
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,46748,-0.181652614403363,0.173738206994014,-0.522179500111631,0.158874271304905,0.295778206106839
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30180.Lymphocyte percentage,46748,-0.00640455701378738,0.00259179896841013,-0.0114844829918712,-0.00132463103570353,0.0134775842716103
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30190.Monocyte percentage,46748,-0.00776970783077805,0.00259808263176951,-0.0128619497890463,-0.00267746587250981,0.002787676280099
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30200.Neutrophill percentage,46748,0.00740174580537644,0.00255140901918197,0.00240098412777978,0.0124025074829731,0.00372277746011197
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30210.Eosinophill percentage,46748,0.00204316592019059,0.00247164330206906,-0.00280125495186477,0.00688758679224596,0.408448218613082
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30220.Basophill percentage,46748,-9.79339883076552e-05,0.00246886399728385,-0.00493690742298399,0.00474103944636868,0.96835845331828
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,46748,-0.178580642554081,0.173701719748884,-0.519036013261894,0.161874728153732,0.303919329811271
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30240.Reticulocyte percentage,46364,0.0052287617986059,0.00264804675661147,3.8590155647408e-05,0.0104189334415644,0.0483288239246492
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30250.Reticulocyte count,46364,0.00769728825629278,0.00271772937705778,0.00237053867725953,0.013024037835326,0.00462627801600508
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,46364,-0.00788811019939544,0.00255801756783391,-0.0129018246323499,-0.00287439576644098,0.00204704162080055
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30270.Mean sphered cell volume,46364,-0.0108088621799634,0.0025672688921059,-0.015840709208491,-0.00577701515143587,2.56070549113456e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,46364,-0.00361241963166265,0.00267184769634673,-0.00884924111650223,0.00162440185317694,0.176379139355768
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46364,0.00267325589589949,0.00270648335603124,-0.00263145148192174,0.00797796327372072,0.323298939987123
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,46364,0.00436589246353465,0.00275433914849758,-0.0010326122675206,0.0097643971945899,0.112958534221047
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30500.Microalbumin in urine,30743,-0.0014165686889398,0.00455684835240001,-0.0103479914596438,0.00751485408176422,0.755911994743695
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,46897,0.000884491298268024,0.00262641179946664,-0.00426327582868659,0.00603225842522264,0.736294908614481
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30520.Potassium in urine,46848,1.87469633139785e-05,0.00243893890377982,-0.00476157328809446,0.00479906721472242,0.993867167971578
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30530.Sodium in urine,46846,-0.0010518127707469,0.00253879970032574,-0.00602786018338535,0.00392423464189155,0.678661725046255
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30600.Albumin,44530,0.00953717757308775,0.0027546288682496,0.00413810499131853,0.014936250154857,0.00053678873022185
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30610.Alkaline phosphatase,46436,0.0108642593043153,0.00259489482323779,0.00577826545076921,0.0159502531578613,2.8400909164614e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30620.Alanine aminotransferase,46426,0.00105866468447032,0.00274400857687185,-0.00431959212619851,0.00643692149513915,0.69964136697892
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30630.Apolipoprotein A,44403,-0.00356734055376037,0.00300218296655529,-0.00945161916820873,0.00231693806068799,0.23474910724758
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30640.Apolipoprotein B,46289,0.013669358981604,0.00263980540658526,0.00849534038469693,0.0188433775785111,2.26008479338087e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,46362,0.00283233319059103,0.00256607457415455,-0.00219717297475188,0.00786183935593394,0.269708604082277
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30660.Direct bilirubin,42876,-0.0081861555638474,0.00285734871084738,-0.0137865590371083,-0.00258575209058653,0.0041753459208469
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30670.Urea,46431,0.00164433445999684,0.00270522614677837,-0.00365790878768876,0.00694657770768245,0.543302213698746
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30680.Calcium,44528,0.0169378797225647,0.00267672926705499,0.0116914903591369,0.0221842690859925,2.53743278249598e-10
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30690.Cholesterol,46441,0.0117667103355941,0.00271367024671392,0.00644791665203478,0.0170855040191533,1.45669474104803e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30700.Creatinine,46435,0.00809413987567386,0.00329672471290274,0.00163255943838449,0.0145557203129632,0.0140878546324975
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30710.C-reactive protein,46367,0.0044061723515253,0.00281344904108494,-0.00110818776900118,0.00992053247205178,0.117336786796655
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30720.Cystatin C,46437,0.0100147163403859,0.00304049180132441,0.00405535240979008,0.0159740802709818,0.000990012666822546
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,46432,0.00306615876944173,0.00280153350088528,-0.00242484689229341,0.00855716443117688,0.27376614705535
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30740.Glucose,44495,0.00251129689682512,0.00272971486533144,-0.0028389442392245,0.00786153803287473,0.35759132033608
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46269,0.0129229314130399,0.00272860454726685,0.00757486650039687,0.0182709963256829,2.19208469783331e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30760.HDL cholesterol,44509,-0.00987342868353121,0.00316608294855176,-0.0160789512626927,-0.00366790610436976,0.00182024212648782
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30770.IGF-1,46333,0.00492766654679974,0.00267193189008675,-0.000309319957770286,0.0101646530513698,0.0651622585092013
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30780.LDL direct,46391,0.0120545786416795,0.00268044542053351,0.00680090561743386,0.0173082516659252,6.91880932604993e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30790.Lipoprotein A,41959,0.00151798597044699,0.00284258345958206,-0.00405347761033386,0.00708944955122783,0.593336798632225
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30810.Phosphate,44478,0.00868636187112773,0.00267068554674505,0.00345181819950744,0.013920905542748,0.00114584959638264
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30830.SHBG,44334,-0.0121696514668084,0.00310647992401893,-0.0182583521178855,-0.0060809508157313,8.97605524741244e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30840.Total bilirubin,46355,-0.00452695500794039,0.00262690660759148,-0.0096756919588197,0.00062178194293891,0.0848475581742088
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30850.Testosterone,44620,0.00816786890168975,0.00445652454102101,-0.000566919198711416,0.0169026570020909,0.0668482775919646
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30860.Total protein,44513,0.0135799907364008,0.00272718734000275,0.00823470354999543,0.0189252779228062,6.42672224274511e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30870.Triglycerides,46423,0.0241995092937049,0.00267880030800809,0.018949060690009,0.0294499578974007,1.78943529371813e-19
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30880.Urate,46417,0.0045617546677576,0.0032507339760377,-0.00180968392527629,0.0109331932607915,0.160541192566045
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30890.Vitamin D,45514,0.00188395973734995,0.00281729287623212,-0.00363793430006501,0.0074058537747649,0.503685845186453
LYZL2,Lysozyme-like protein 2,Physical measures,X3137.Number of measurements made,45593,0.00465220300915194,0.0406945732670873,-0.0751091605943392,0.0844135666126431,0.90898519663607
LYZL2,Lysozyme-like protein 2,Physical measures,X3143.Ankle spacing width,37199,-0.0169066422784488,0.00464983300625059,-0.0260203149706999,-0.00779296958619759,0.00027798162018581
LYZL2,Lysozyme-like protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37198,-0.00499965533967052,0.00355082166185056,-0.0119592657968976,0.00195995511755658,0.159146167493231
LYZL2,Lysozyme-like protein 2,Physical measures,X3146.Speed of sound through heel,37199,-0.00106890344157751,0.00345839548680485,-0.00784735859571501,0.00570955171256,0.757269334645731
LYZL2,Lysozyme-like protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37199,-0.00263503030121574,0.00348932141376061,-0.00947410027218654,0.00420403966975505,0.450160414540366
LYZL2,Lysozyme-like protein 2,Physical measures,X3148.Heel bone mineral density (BMD),37189,-0.00113594635367972,0.00349041192089953,-0.0079771537186428,0.00570526101128335,0.744847406200268
LYZL2,Lysozyme-like protein 2,Health and medical history,X3526.Mother's age at death,33450,-0.00547196360638443,0.00459526525876181,-0.0144786835135576,0.00353475630078871,0.23376826966177
LYZL2,Lysozyme-like protein 2,Health and medical history,X3581.Age at menopause (last menstrual period),29342,0.00137782890226302,0.00610148612406214,-0.0105810839008988,0.0133367417054248,0.821350946033616
LYZL2,Lysozyme-like protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29276,0.00532441010727217,0.00580376918015147,-0.00605097748582471,0.016699797700369,0.358971010676294
LYZL2,Lysozyme-like protein 2,Physical measures,X4100.Ankle spacing width (left),31439,-0.0022707989181917,0.00611656382207633,-0.0142592640094613,0.00971766617307791,0.710458717169567
LYZL2,Lysozyme-like protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31439,0.00119246940221958,0.00465795166343229,-0.00793711585810771,0.0103220546625469,0.797952185959407
LYZL2,Lysozyme-like protein 2,Physical measures,X4103.Speed of sound through heel (left),31439,0.00063027740357945,0.00456020978160025,-0.00830773376835703,0.00956828857551593,0.890076250526081
LYZL2,Lysozyme-like protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31439,0.000859987043521738,0.00459557968598559,-0.00814734914101002,0.0098673232280535,0.851560949364971
LYZL2,Lysozyme-like protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),31433,0.000365766256828573,0.00460164368658848,-0.00865345536888485,0.00938498788254199,0.936648165783965
LYZL2,Lysozyme-like protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31439,0.000863730486141486,0.00459563435007852,-0.00814371284001242,0.00987117381229539,0.850924117571732
LYZL2,Lysozyme-like protein 2,Physical measures,X4119.Ankle spacing width (right),31428,-0.00372856168091378,0.00602688484815857,-0.0155412559833046,0.00808413262147702,0.536162363887816
LYZL2,Lysozyme-like protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31428,0.0017008397047623,0.00471796047267871,-0.00754636282168797,0.0109480422312126,0.718480947754012
LYZL2,Lysozyme-like protein 2,Physical measures,X4122.Speed of sound through heel (right),31428,0.00316807828764802,0.00459047189905149,-0.00582924663449289,0.0121654032097889,0.490125942234977
LYZL2,Lysozyme-like protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31428,0.00282619371036025,0.00463724653996036,-0.00626280950796206,0.0119151969286825,0.542241098662188
LYZL2,Lysozyme-like protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),31421,0.00275946046837363,0.00464675647206286,-0.00634818221686958,0.0118671031536168,0.552632492334906
LYZL2,Lysozyme-like protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31428,0.00282328140831185,0.00463727849537826,-0.00626578444262954,0.0119123472592532,0.542660096999777
LYZL2,Lysozyme-like protein 2,Physical measures,X4194.Pulse rate,31700,-0.0013755010006522,0.00443581872778737,-0.0100697057071154,0.00731870370581104,0.756501106400704
LYZL2,Lysozyme-like protein 2,Physical measures,X4195.Pulse wave reflection index,31700,0.00872784683840039,0.00430055846369102,0.000298752249565997,0.0171569414272348,0.0424443307780959
LYZL2,Lysozyme-like protein 2,Physical measures,X4196.Pulse wave peak to peak time,31695,-0.00685475849869258,0.00460807354425484,-0.0158865826454321,0.0021770656480469,0.136908779206041
LYZL2,Lysozyme-like protein 2,Physical measures,X4198.Position of the pulse wave peak,31700,0.00243404218781145,0.00442824592256454,-0.00624531982041505,0.011113404196038,0.582566312107706
LYZL2,Lysozyme-like protein 2,Physical measures,X4199.Position of pulse wave notch,31700,-0.00175804049773952,0.00437035922828925,-0.0103239445851865,0.0068078635897074,0.687500322840168
LYZL2,Lysozyme-like protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,31700,0.000838885733300216,0.00453557708932408,-0.00805084536177498,0.00972861682837542,0.85326771945897
LYZL2,Lysozyme-like protein 2,Physical measures,X4269.Number of triplets attempted (left),31569,-0.0733045676036447,0.187253076150706,-0.440320596859029,0.293711461651739,0.695458307776579
LYZL2,Lysozyme-like protein 2,Physical measures,X4270.Volume level set by participant (left),31492,-0.147206707050919,0.0553926784891931,-0.255776356889738,-0.0386370572121006,0.007888383984942
LYZL2,Lysozyme-like protein 2,Physical measures,X4276.Number of triplets attempted (right),31578,-0.142102890557869,0.181112175497027,-0.497082754532042,0.212876973416304,0.432704876150677
LYZL2,Lysozyme-like protein 2,Physical measures,X4277.Volume level set by participant (right),31495,-0.0408733905608829,0.0548286917131742,-0.148337626318704,0.0665908451969384,0.456007889243933
LYZL2,Lysozyme-like protein 2,Cognitive function,X4288.Time to answer,31722,-0.0030446837698285,0.00505315477354039,-0.0129488671259677,0.00685949958631066,0.546837931675684
LYZL2,Lysozyme-like protein 2,Cognitive function,X4290.Duration screen displayed,31722,-0.00678119556765288,0.00442040141724759,-0.0154451823454581,0.0018827912101524,0.125053206865083
LYZL2,Lysozyme-like protein 2,Physical measures,X46.Hand grip strength (left),47481,-0.00258516182743512,0.00351731303512735,-0.00947909537628473,0.00430877172141449,0.46235774321277
LYZL2,Lysozyme-like protein 2,Physical measures,X47.Hand grip strength (right),47464,-0.00413216374178403,0.00349790558530024,-0.0109880586889725,0.00272373120540444,0.237485493309163
LYZL2,Lysozyme-like protein 2,Physical measures,X48.Waist circumference,47531,0.00728019130042621,0.00551512213929342,-0.0035294480925889,0.0180898306934413,0.186833854791445
LYZL2,Lysozyme-like protein 2,Health and medical history,X4803.Tinnitus,31528,-0.0828278506303251,0.06941687702783,-0.218884929604872,0.0532292283442216,0.232830055857605
LYZL2,Lysozyme-like protein 2,Working and living environment,X4825.Noisy workplace,31654,-0.0437682672012323,0.0774714595446729,-0.195612327908791,0.108075793506327,0.572117311150299
LYZL2,Lysozyme-like protein 2,Working and living environment,X4836.Loud music exposure frequency,31600,-0.0601169476979885,0.0823859017292561,-0.22159331508733,0.101359419691353,0.465596001289175
LYZL2,Lysozyme-like protein 2,Physical measures,X49.Hip circumference,47528,-0.00533653175882194,0.00436327597790585,-0.0138885526755174,0.00321548915787352,0.221320645918712
LYZL2,Lysozyme-like protein 2,Physical measures,X50.Standing height,47502,-0.00872153782767559,0.00345972456649728,-0.0155025979780103,-0.00194047767734093,0.0117128208969956
LYZL2,Lysozyme-like protein 2,Health and medical history,X5057.Number of older siblings,31000,4.65717063087731e-05,0.0578293185174905,-0.113298892587973,0.11339203600059,0.999357461904617
LYZL2,Lysozyme-like protein 2,Physical measures,X51.Seated height,47389,-0.00652404445449881,0.00320577431330759,-0.0128073621085817,-0.000240726800415944,0.0418528395063018
LYZL2,Lysozyme-like protein 2,Eye measures,X5181.Ever had eye surgery,29186,0.0762399523147107,0.147429574826929,-0.21272201434607,0.365201918975492,0.605088332931268
LYZL2,Lysozyme-like protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29175,0.00701392860060689,0.00539041400590129,-0.00355128285095964,0.0175791400521734,0.193251365831808
LYZL2,Lysozyme-like protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29174,0.00321617315615164,0.00533476997975987,-0.0072399760041777,0.013672322316481,0.546620854389539
LYZL2,Lysozyme-like protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),29123,0.00302635949469796,0.00527214670631102,-0.00730704804967164,0.0133597670390676,0.565973427276292
LYZL2,Lysozyme-like protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),29122,0.00777493206136822,0.00530433941908355,-0.00262157320003554,0.018171437322772,0.142771196645296
LYZL2,Lysozyme-like protein 2,Eye measures,"X5199.logMAR, initial (right)",29151,0.0308516308105497,0.0692386196560776,-0.104856063715362,0.166559325336462,0.655915902957525
LYZL2,Lysozyme-like protein 2,Eye measures,X5200.Final number of letters displayed (right),29151,0.037091938293156,0.539464825302777,-1.02025911930029,1.0944429958866,0.945185711196954
LYZL2,Lysozyme-like protein 2,Eye measures,"X5201.logMAR, final (right)",29108,0.00110890565578524,0.00509452007036454,-0.00887635368212926,0.0110941649936997,0.827697535767925
LYZL2,Lysozyme-like protein 2,Eye measures,X5202.Number of rounds to result (right),29151,0.0225691655895303,0.0661912664038469,-0.10716571656201,0.15230404774107,0.733140534958868
LYZL2,Lysozyme-like protein 2,Eye measures,"X5206.logMAR, initial (left)",29151,-0.0299623830937694,0.0683650021894658,-0.163957787385122,0.104033021197584,0.661207898073626
LYZL2,Lysozyme-like protein 2,Eye measures,X5207.Final number of letters displayed (left),29151,0.0414291493126421,0.503324313227308,-0.945086504612882,1.02794480323817,0.934402487676051
LYZL2,Lysozyme-like protein 2,Eye measures,"X5208.logMAR, final (left)",29110,0.00186936663334749,0.00515371594145132,-0.00823191661189709,0.0119706498785921,0.716827095624153
LYZL2,Lysozyme-like protein 2,Eye measures,X5209.Number of rounds to result (left),29147,0.00700842451719042,0.0664649226588134,-0.123262823894084,0.137279672928465,0.91602635165153
LYZL2,Lysozyme-like protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",28944,0.00546663848837582,0.00534605510928918,-0.00501162952583097,0.0159449065025826,0.306566673728387
LYZL2,Lysozyme-like protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",28944,0.00777519127609319,0.00524977908787394,-0.00251437573613973,0.0180647582883261,0.138654917606223
LYZL2,Lysozyme-like protein 2,Eye measures,X5256.Corneal hysteresis (right),28944,0.00282247326298361,0.00536881936920161,-0.00770041270065156,0.0133453592266188,0.599108600741518
LYZL2,Lysozyme-like protein 2,Eye measures,X5257.Corneal resistance factor (right),28944,0.00678682417854435,0.00525844821726392,-0.00351973432729293,0.0170933826843816,0.196883233079469
LYZL2,Lysozyme-like protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",28922,0.00612680860919606,0.00537290303820989,-0.00440408134569532,0.0166576985640874,0.254208522435573
LYZL2,Lysozyme-like protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",28922,0.00453943500697172,0.00526879989048716,-0.00578741277838312,0.0148662827923266,0.388965508755557
LYZL2,Lysozyme-like protein 2,Eye measures,X5264.Corneal hysteresis (left),28922,-0.00415202050786692,0.00535051757734954,-0.014639034959472,0.00633499394373817,0.437783157560596
LYZL2,Lysozyme-like protein 2,Eye measures,X5265.Corneal resistance factor (left),28922,-0.00102932540937834,0.00526051441206475,-0.0113399336570252,0.00928128283826857,0.844876238230621
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29005,0.148323691629634,0.280994014049233,-0.402424575906863,0.69907195916613,0.597623744742391
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47456,-0.00120377825648825,0.0148120608059151,-0.0302354174360818,0.0278278609231053,0.935227809466072
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47456,-0.0219576059243819,0.0163284157662512,-0.0539613008262342,0.0100460889774703,0.178719524350237
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47456,-0.00372275149585061,0.0406529753318197,-0.0834025831462172,0.075957080154516,0.927037366467777
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47456,-0.00397479809222149,0.00687976471328533,-0.0174591369302607,0.00950954074581776,0.563437052786157
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47456,0.00327908596864839,0.00617263729079318,-0.00881928312130624,0.015377455058603,0.595264871289168
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35624,-0.00275089586432404,0.0071704740680706,-0.0168050250377424,0.0113032333090943,0.701250651042574
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35624,-0.0438249846676249,0.0248350390544446,-0.0925016612143364,0.00485169187908653,0.0776496825922212
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35624,0.00938310323834475,0.0122620539459151,-0.0146505224956488,0.0334167289723383,0.444159092101072
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35624,0.00787856535281481,0.007752389946118,-0.00731611894157647,0.0230732496472061,0.309519027359656
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47520,-0.0118305189830178,0.0138191324621582,-0.038916018608848,0.0152549806428123,0.391952752130932
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47520,-0.0118305189830178,0.0138191324621582,-0.038916018608848,0.0152549806428123,0.391952752130932
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47520,-0.00760452315464919,0.0102468974557159,-0.0276884421678523,0.0124793958585539,0.458016347209439
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47520,-0.00729306001758138,0.0159297818982146,-0.038515432538082,0.0239293125029192,0.647082033850505
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47520,0.0569757947555469,0.0387164917707635,-0.0189085291151496,0.132860118626243,0.141138000184807
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47520,0.045978305922696,0.0276792417336681,-0.00827300787529345,0.100229619720685,0.0967043106767086
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47520,0.0304738200760532,0.0427214362089082,-0.0532601948934069,0.114207835045513,0.475658199897163
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47455,0.00175296198533846,0.0079067557183168,-0.0137442792225625,0.0172502031932394,0.824545977176753
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47455,-0.00093075169255393,0.0135300484906731,-0.0274496467342733,0.0255881433491654,0.945156204552203
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47455,-0.00681168283371811,0.00662698887602096,-0.0198005810307192,0.00617721536328297,0.304021535591828
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47455,-0.00238759862593422,0.0123598404704436,-0.0266128859480037,0.0218376886961353,0.846824438760762
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47455,-0.0129611232910654,0.0107413727160135,-0.0340142138144518,0.00809196723232105,0.227577413476511
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47455,0.00210000091228442,0.00872471055194541,-0.0150004317695286,0.0192004335940974,0.809793009968653
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29125,0.0538060769104434,0.0231277267431477,0.00847573249387396,0.0991364213270129,0.0200309870666099
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29125,-0.0108199375207238,0.0203711406690761,-0.050747373232113,0.0291074981906653,0.595343836653404
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29125,-0.0166169979077324,0.0251619921153019,-0.0659345024537241,0.0327005066382594,0.509025596274241
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29125,-0.0118902214489653,0.0208135691549984,-0.0526848169927621,0.0289043740948314,0.567839266375302
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47415,-0.0250238821701159,0.0217274396967878,-0.06760966397582,0.0175618996355881,0.249448685795336
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47415,-0.0222977810246947,0.0316385408956312,-0.0843093211801318,0.0397137591307425,0.480962580796241
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47415,0.0136197296489443,0.0664657850077734,-0.116653208966292,0.14389266826418,0.837641560243143
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47415,0.118189480239144,0.0531636371764244,0.0139887513733526,0.222390209104936,0.0262167365556929
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47415,0.0159808062397518,0.0201445226122257,-0.0235024580802105,0.0554640705597142,0.427606523749488
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47415,0.0229981529757221,0.0256180256242439,-0.0272131772477959,0.0732094831992401,0.369336962941375
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47415,0.00574419861476906,0.0105400724526982,-0.0149143433925194,0.0264027406220575,0.58576786966231
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32047,-0.0256676590632502,0.0197174389804461,-0.0643138394649246,0.0129785213384242,0.193030113177959
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32047,-0.013201166628895,0.021872469271687,-0.0560712064014015,0.0296688731436116,0.546158435335352
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32047,-0.0548888910676307,0.0282494201311991,-0.110257754524781,0.000479972389519606,0.0520492469286757
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32047,0.00384145048380161,0.00852612832327173,-0.012869761029811,0.0205526619974142,0.652325556216612
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",33852,-2.30517777592902e-05,0.009541281952948,-0.0187239644055374,0.0186778608500188,0.998072357614992
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",33852,0.0036289668415322,0.00773941361077631,-0.0115402838355894,0.0187982175186538,0.639155428455974
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",33852,0.00872866406536933,0.00764684153817732,-0.00625914534945822,0.0237164734801969,0.253700446653716
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",33853,-0.0270680812463037,0.0183993019390414,-0.0631307130468249,0.00899455055421755,0.141282804407588
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",33853,-0.00268492031001075,0.0120171748772863,-0.0262385830694919,0.0208687424494704,0.823210415836661
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",33853,0.0118908589723787,0.015306235885191,-0.0181093633625956,0.041891081307353,0.437257580747614
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47455,-0.0233058195032994,0.0183946849386826,-0.0593594019831173,0.0127477629765185,0.205172583407605
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47455,-0.00643489463679157,0.0118899670059109,-0.0297392299683769,0.0168694406947937,0.588372268028918
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47455,0.0386301025864287,0.0364774155255949,-0.0328656318437374,0.110125837016595,0.289604134238665
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47455,0.00426280182377548,0.0134717189294552,-0.0221417672779567,0.0306673709255076,0.751682001513469
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47455,-0.0347574714383633,0.0148653755379274,-0.0638936074927011,-0.00562133538402556,0.0193877990921099
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47455,0.0269820023172023,0.0161566725793378,-0.00468507593829976,0.0586490805727043,0.094928230421314
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47455,0.00173860950482838,0.0053012573997851,-0.00865185499875041,0.0121290740084072,0.742943514850877
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27442,-0.00415581595323283,0.0166451919106083,-0.0367803920980251,0.0284687601915594,0.802856370506611
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27442,0.00878007679506768,0.0213357681663208,-0.0330380288109211,0.0505981824010565,0.680716535997971
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27442,-0.00689371764599374,0.0157111895955806,-0.0376876492533317,0.0239002139613442,0.660849175078693
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27442,0.0198848020084915,0.0131309713155156,-0.00585190176991912,0.0456215057869021,0.130026951311963
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47566,0.00472776998684568,0.00567901758059194,-0.00640310447111452,0.0158586444448059,0.405136371620279
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47566,0.00330766490154503,0.0166366652462848,-0.0293001989811732,0.0359155287842633,0.842406989839705
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47566,-0.00356302479917616,0.00572541782635948,-0.0147848437388407,0.00765879414048842,0.533739435751149
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47566,0.00354480307014747,0.00557318000704781,-0.00737862974366624,0.0144682358839612,0.524752087303669
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47566,0.000347709134418475,0.00809168493694484,-0.0155119933419934,0.0162074116108304,0.965724880939547
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47566,0.00342994792212844,0.00824629812275845,-0.0127327963984781,0.019592692242735,0.677459210632224
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47566,0.00630463502563629,0.00614696041484708,-0.00574340738746397,0.0183526774387366,0.305066666312201
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47566,-0.00987836836465903,0.0170864030261308,-0.0433677182958755,0.0236109815665574,0.563173699544279
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,39892,-0.00584313604322409,0.00608562893653577,-0.0177709687588342,0.00608469667238603,0.336992601274346
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,39892,0.0033935295348513,0.00638849217459452,-0.00912791512735396,0.0159149741970566,0.595291620045671
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,39892,0.00133328510230954,0.00762357941932132,-0.0136089305595602,0.0162755007641793,0.86116855504387
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,39893,-0.00659839596804484,0.0104505560417031,-0.027081485809783,0.0138846938736933,0.527793341393021
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,39893,0.00170228200877403,0.00677055454845014,-0.0115680049061882,0.0149725689237363,0.801489296479099
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47366,0.00451981299250598,0.0062787857705719,-0.00778660711781495,0.0168262331028269,0.471621663644217
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47366,0.00456381296069514,0.00493887616267382,-0.00511638431814555,0.0142440102395358,0.355465084630894
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47366,0.003047750703026,0.00588073251199069,-0.00847848502047575,0.0145739864265277,0.604281485827931
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47366,0.0094879093800385,0.00919381857818942,-0.00853197503321276,0.0275077937932898,0.302088411100617
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47380,-0.000108857419752557,0.00541090499386019,-0.0107142312077185,0.0104965163682134,0.983949288960626
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47380,0.00543118263516975,0.00749348585111496,-0.00925604963301558,0.0201184149033551,0.468589799021249
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47455,0.010214169666941,0.00572262937377124,-0.00100218390565064,0.0214305232395326,0.0742946766423793
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47455,0.00696347850833654,0.00709319905536575,-0.00693919164018032,0.0208661486568534,0.326251826261973
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47455,-0.00556143004591208,0.0105364804817743,-0.0262129317901898,0.0150900716983656,0.597624961099256
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47455,-0.0158553570316538,0.0124926425529877,-0.0403409364355096,0.00863022237220208,0.204390962673387
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47455,0.0196720176245848,0.0120421202792462,-0.00393053812273786,0.0432745733719074,0.102356036441661
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47455,-0.0135559698756275,0.0175984955404513,-0.0480490211349119,0.020937081383657,0.44113476521844
LYZL2,Lysozyme-like protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37199,-0.00263597115322456,0.00348934522918275,-0.00947508780242274,0.00420314549597362,0.450001763770227
LYZL2,Lysozyme-like protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,47120,-0.0272517769309206,0.0317438365741341,-0.0894696966162234,0.0349661427543822,0.390630613082009
LYZL2,Lysozyme-like protein 2,Physical activities,X874.Duration of walks,44041,0.00118846769218158,0.00255581867082014,-0.00382093690262589,0.00619787228698906,0.641933108516424
LYZL2,Lysozyme-like protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46489,-0.0368464947532125,0.0309802297705623,-0.0975677451035146,0.0238747555970896,0.234312438039523
LYZL2,Lysozyme-like protein 2,Physical activities,X894.Duration of moderate activity,41343,0.016021802170313,0.037226853452957,-0.0569428305974828,0.0889864349381088,0.666922417689409
LYZL2,Lysozyme-like protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29063,-0.015244548711085,0.00550272072226023,-0.0260298813267151,-0.00445921609545494,0.00561920889239917
LYZL2,Lysozyme-like protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46506,-0.0105463718602991,0.0314887416781901,-0.0722643055495517,0.0511715618289534,0.737684644692255
LYZL2,Lysozyme-like protein 2,Physical activities,X914.Duration of vigorous activity,37171,-0.00605377698085659,0.0033030929328964,-0.0125278391293335,0.000420285167620359,0.0668605768936475
